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Magic's just science that we don't understand yet. 






The C2-domain containing protein otoferlin is required for a late step in exocytosis 
from auditory inner hair cells and was hypothesized to act as a synaptic Ca2+-sensor. 
More roles for otoferlin in hair cell synaptic function have been proposed but have 
just begun being studied.  
To address the questions for potential interaction partners of otoferlin or its overall 
structure several C2-domain containing protein fragments were expressed and 
purified from E. coli. The known ability of C2-domains to bind Ca2+ was tested using 
MicroScale Thermophoresis (MST) and revealed no indication for Ca2+-binding within 
the first three C2-domains of the protein while the otoferlin C2F-domain gave a 
distinct signal for Ca2+-binding. Additionally the roles of the present aspartate 
residues within the binding region were analyzed, revealing that mutations in these 
aspartate residues reduced Ca2+-binding to a similar degree. It seems that in all cases 
the structure is affected in a comparable way, leading to a 10-fold increase in the Kd. 
Further tested mutations known to affect hearing showed a similar decrease in 
Ca2+-binding. In order to identify phosphorylation sites in the protein two long 
otoferlin fragments were incubated with CaMKIIδ which resulted in ten 
phosphorylation sites. Ca2+-binding studies revealed that the incorporated aspartate 
residues mimicking phosphorylation sites within the C2C- and C2F-domain of the 
protein affect the Ca2+-binding affinity in different ways. For the C2C-domain an 
increase in the affinity to bind Ca2+ was found whereas the incorporated aspartate 
residues within the C2F-domain led to a ten-fold decreased affinity. Pull-down 
experiments were performed to get information about potential interaction partners 
of otoferlin which are assumed to play a role within the unknown synaptic 
mechanism of otoferlin action. Several of the identified interacting proteins are 
involved in endocytosis, exocytosis or trafficking processes. In ongoing studies these 
potential interaction partners are currently validated. Thermal shift experiments of 
the purified otoferlin C2-domains displayed that the melting temperature of a 
C2-domain can be increased either in presence of Ca2+ or neighboring C2-domains. 
This reveals that the Ca2+-binding in some C2-domains probably play an essential role 
in the function of the protein whereas complex forming of two or three C2-domains 
increases the stability of the whole protein. In addition the C2ABC-I515T-mutant 
displayed a decrease in thermal stability in comparison to the wild type fragment, 
giving a molecular mechanism explaining how the I515T mutation leads to 
temperature sensitive deafness in humans. 
For further analysis regarding the overall structure of the protein, crystals were 
obtained containing the first three C2-domains. Solving the structure is still an 
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1.1 Hearing  
The ear is subdivided into three parts: the air-filled external and middle ear and the 
fluid-filled inner ear. Within the inner ear is the vestibular system, responsible for the 
sense of balance, and the cochlea which is the location of the organ of hearing. The 
cochlea is composed of three fluid-filled canals, namely scala vestibuli, scala tympani 
and scala media, which spiral up together in approximately two and a half turns in 
humans. The scala tympani and scala vestibuli are filled with perilymph whereas the 
scala media is filled with endolymph which contains a high K+-concentration 
(150 mM). Scala media and scala tympani are separated by the basilar membrane on 
which the organ of Corti is located. This organ amplifies the mechanical input signal 
evoked by sound and transduces it into an electrical output signal which is then 
transferred to the brain.  
The organ of Corti comprises two sorts of hair cells, the outer hair cells (OHC) which 
are organized in three rows and the inner hair (IHC) cells forming only one row, both 
types running the length of the cochlea. Stereocilia are long extensions located on the 
apical part of both types of hair cells. Outer hair cell stereocilia are in direct contact 
with the overlaying tectorial membrane whereas the inner hair cells are not.  
During the hearing process sound waves enter the outer ear and travel through the 
external auditory canal until they reach the tympanic membrane, causing the 
membrane and the attached chain of auditory ossicles to vibrate. The motion of the 
stapes against the oval window sets up waves in the fluid of the cochlea. Such a wave 
leads to oscillations of the basilar and tectorial membrane. Resulting shear 
movements cause the deflection of the OHC stereocilia and mechanoelectrical 
transduction channels in the tips of the stereocilia of the hair cells are opened. 
Through potassium (K+) influx the hair cell is depolarized and the OHCs undergo an 
oscillation-based alternation of length. These amplified oscillations are transferred 
back to the basilar and tectorial membrane and also to the fluid-filled interspace 
between the OHCs and the tectorial membrane. Movement in this endolymphatic fluid 
causes the depolarisation of the IHC stereocilia. The deflection of the stereocilia 
results like in the case of the OHCs stereocilia to transduction channel opening. K+ 
enters and depolarizes the cell and leads to the opening of voltage-dependent 




glutamate-filled vesicles at the ribbon synapses of the IHCs and the released 
glutamate binds to postsynaptic glutamate receptors. At this point the sound signal is 




Figure 1.1–1 Anatomy of the mammalian cochlear, modified from Inaoka et al., 2011.  
A Overview of the ear. Sound waves are transmitted via the tympanic membrane and the attached 
chain of ossicles to the cochlea. 
B Cross section through the cochlea.  
C Cross section of one cochlear duct with its three fluid filled channels and the organ of Corti located on 
the basilar membrane.  
D Enlarged picture of the organ of Corti containing the inner and outer hair cells. 
 
In conventional synapses vesicle exocytosis is known to be mediated by the soluble 
N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex and 
is triggered by Ca2+-binding to synaptotagmin 1 (Syt 1) or Syt 2 [6,7]. The proteins 
synaptobrevin, syntaxin 1 and the 25-kilo Dalton (kDa) synaptosome associated 
protein (SNAP-25) form the SNARE complex in a parallel four-helix bundle structure 
[8,9]. In biochemical and functional studies, synaptotagmin 1 and 2 were reported as 
the primary Ca2+ sensors for exocytosis at neuronal synapses. In case of the mature 
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Ca2+-trigger was proposed [10–13]. Based on experiments which show that otoferlin 
C2-domains stimulate membrane fusion in a Ca2+-dependent manner as well as the 
binding to SNAREs and Ca2+-channels otoferlin was proposed to be the hair cell 
specific Ca2+-sensor for exocytosis [11,14,15].  
 
 
Figure 1.1–2 Model of the SNARE complex in all neuronal synapses, modified from Sutton et al., 1998.  
 
1.2 Deafness 
The most prevalent sensory deficit is hearing impairment. One in 1000 children is 
affected by severe or profound hearing loss at birth and the same number become 
deaf before adulthood [16]. About 50 % of hearing losses have genetic reasons, which 
can be divided into two main categories. 10 % of the hearing impaired people are 
affected by syndromic hearing impairment, which is accompanied by over 500 
different disorders [16,17]. The remaining 90 % are affected by a non-syndromic 
form of hearing impairment, which is not associated with other symptoms. For this 
type of deafness different types of inheritance are known, like the autosomal 
dominant deafness (DFNA), autosomal recessive deafness (DFNB) and an x-linked 
deafness (DFNX). About 80 % of the affected people suffer from DFNB and 23 genes 
can be linked to it. In case of DFNB9 the affected protein was identified as otoferlin, 
which belongs to the ferlin family [18]. Mutations within the protein lead to moderate 
or profound hearing loss caused by an incorrectly transmitted auditory signal to the 
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1.3 The ferlin protein family  
Otoferlin is a member of the ferlin protein family comprising 200 - 240 kDa proteins 
which are assumed to play a role in membrane trafficking and vesicle fusion. In 
addition to the six proteins in Table 1.3-1 more ferlin proteins (FerIL4, Fer1L5, 
Fer1L6) are known but their function is still uncharacterized. All family members 
contain multiple C2-domains, a highly conserved C-terminal C2B-FerI-C2C motif and a 
single C-terminal transmembrane domain. The sequence homology is high among 
ferlin C2-domains but low in comparison to non-ferlin C2-domains [20]. Among the 
ferlin family the domains C2E and C2F share high similarities [20,21].  
Due to the absence or presence of the domains DysF and FerA, the proteins can be 
subdivided into two types (Figure 1.3–1). In type I ferlins, DysF and FerA are present 
whereas in type II both domains are lacking. FerI, FerA and FerB are ferlin-specific 
motifs of 60-70 residues the function of which is still unknown. Similar to otoferlin, 
missense mutations occur also in other ferlin proteins and result in different diseases. 
Misfire and Fer-1 mutations for example cause infertility in Drosophila and C. elegans, 




Figure 1.3–1 Overview of ferlin domain topologies, modified from Lek et al., 2012. Ferlins of the type I 
form contain the additional FerA and DysF domains which are missing in type II ferlins. Conserved 
C2-domains are shown in green, FerI domains in purple, FerB domains in yellow and the 
transmembrane domains in grey. The optional domains FerA and DysF are shown in red and 








Table 1.3-1 Phenotypes of ferlin disease and animal models, modified from Lek et al., 2010. 
protein model phenotype 
Misfire Drosophila Infertility 
Fer-1 C. elegans Infertility 
Sea urchin ferlin Sea urchin Defective exocytosis 
Dysfelin Mouse - Mild progressive muscle wasting 
- Severe progressive myopathy 
 Human Muscular dystrophy 
Otoferlin Mouse Deafness 
 Human Deafness 
Myoferlin Mouse Impaired myofibre growth and regeneration 
 
1.4 Otoferlin 
Otoferlin is a 220 kDa protein, containing a C-terminal transmembrane domain, a 
coiled-coil domain, a FerB-domain in the middle and at least six C2-domains (Figure 
1.4–1). The C2-domains are named from A to F starting at the N-terminus. The 
seventh C2-domain is predicted to exist between the C2D- and C2E-domain of the 
protein and thus named C2de, however, its existence could not be proven so far 
[21,23,24].  
 
Figure 1.4–1 Scheme of otoferlin with its different domains and the known single amino acid 
mutations. The six confirmed C2-domains are shown in green and the predicted C2de is marked with a 
dotted line. The upper mutations are pathogenic missense mutations and in-frame deletions. In the 
lower part sequence variants are shown. The mutations in violet result in temperature-sensitive 
hearing loss. Modified from Pangršič et al., 2012.  
 
Additionally, a predicted FerI-domain was published [25] which comprises the amino 
acids 354 to 425 in human otoferlin. This entails that the last β-strand of the 




Otoferlin is found in the brain, the vestibular system and the cochlea where it is 
localized in the cytoplasm and at the presynaptic membrane of the inner hair cells 
[22].  
Recent studies showed that the neuronal SNAREs are not required for exocytosis in 
inner hair cells [10,26,27]. The exocytosis in IHCs was examined in the presence of 
different botulinum neurotoxin serotypes (BoNT) which are known to cleave 
SNAP-25, syntaxin and synaptobrevin. No significant changes in IHC exocytosis were 
detected between samples containing BoNTs and BoNT-free samples. Single-IHC PCR 
experiments showed that SNARE proteins are expressed in the organ of Corti but in 
lower concentrations than otoferlin. The analysis of IHCs from synaptobrevin-2 
and -3 double knockout mice showed normal/unaltered exocytosis. These findings 
lead to the assumption that SNARE proteins are present in the IHCs in a low amount, 
but neither the cleavage nor the knockout of SNARE proteins has significant effects on 
IHC exocytosis. It was concluded that exocytosis from IHCs does not require neuronal 
SNARE proteins [26].  
The precise function of otoferlin is still unknown, however, next to the suggested role 
as a Ca2+-sensor some other functions were proposed [11,14,15]. Roux et al. showed 
that in the absence of otoferlin the vesicle fusion nearly vanished. This leads to the 
assumption that otoferlin is essential in a late step of exocytosis [11]. Pangršič et al. 
published a role for otoferlin in sustained exocytosis based on studies of the 
pachanga mutation in mice (pga). Pachanga is a point mutation (D1767G) found in a 
random mutagenesis screen and affects an amino acid in the C2F-domain of the 
protein. The exocytosis was measured using patch-clamp electrophysiology. The cells 
were depolarized to the potential where maximum Ca2+-currents were elicited. The 
sustained exocytosis evoked by long term depolarization steps (>10 ms) was reduced 
compared to the wild type. One explanation for this finding could be a defect in 
vesicle replenishment. In a further electron microscopic experiment the cell was 
depolarized with high K+-concentrations for 15 min. After this procedure the detected 
number of vesicles at the active zone in pga and wild type was similar. This suggested 
that the pga mutation has no influence on the docking process of vesicles, thus it was 
concluded that priming is impaired due to this mutation in otoferlin [28]. 
 
1.4.1 C2-domains 
C2-domains are part of many proteins; the first C2-domain was found in the 
Ca2+-dependent isoform of protein kinase C (PKC)[29,30]. Up to now, approximately 




proteins contain two to seven C2-domains [22] which are involved in membrane 
trafficking, signal transduction, protein-protein interaction or Ca2+-mediated 
phospholipid binding [29,32]. They are also found in processes like generation of 
lipid-second messengers, activation of GTPases or control of protein phosphorylation 
[29]. 
In general, C2-domains are capable to interact with several ligands. Besides Ca2+ and 
phospholipid binding, C2-domains also interact with src homology 2 (SH2), 
phosphotyrosine binding domains (PTB domains), pleckstrin homology domains 
(PH domains) of phosphatidylinositol phosphatases, proline-rich sequences of src 
homology 3 (SH3) and WW domains, and C-terminal sequences of post-synaptic 
density protein domains (PDZ) [32].  
C2-domains consist of approximately 130 residues in length [29] and they are formed 
as an eight-stranded antiparallel β-sandwich, which can adopt two structural 
arrangements, type I and II (Figure 1.4–2). The types are related by a circular 
permutation which leads to a slightly different connectivity between the β-strands 
[22,29,31]. Theoretically, type I can be transformed into type II by fusion of the type I 
N-terminal β-strand to the C-terminus [29]. One reason for the occurrence of two 
different topologies could be the influence of the relative orientation of a C2-domain 
with respect to its neighboring domain [32]. C2-domains share a high structural 
homology within their core β-sandwiches and a low similarity in the top and bottom 
loops [32]. The Ca2+-binding takes place exclusively at the top loops of the domain 
[32]. For the coordination of two to three Ca2+-ions in the top loop region negatively 
charged residues, primarily aspartate side chains, are needed [22]. These amino acids 
are located at specific positions in the top loops 1 and 3 [31].  
The Ca2+-ions bound to the top loops of the C2-domain often remain with unsaturated 
coordination sites which are available for interaction with other target molecules 
[32]. These free coordination sites can interact with lipids. For several C2-domains it 
was reported that lipid binding is mediated by Ca2+ [31,33]. The binding of  
phospholipids can either take place simultaneously with Ca2+ to the top loops or 
independently of Ca2+ to the β-groove [31]. The β-groove is a cationic patch in the 
concave surface of the β-sandwich, which is often found in C2-domains. The 
electrostatic potential and the size of the β-groove vary widely among the domains. 
The presence of the β-groove in most C2-domains leads to the assumption that it 






Figure 1.4–2 Typical structure of a C2-domain .  
A Schematic presentation of the two possible C2-domain arrangements, modified from Nalefski et al., 
1996.  
B C2A domain of synaptotagmin 1, the bound Ca2+-ions are shown in yellow and the coordinating loops 
1 and 3 in green, modified from Vrljic et al., 2010, (PDB 3HN8). 
 
Some C2-domains were found with little or no Ca2+-affinity which suggests that they 
may play a role in structural arrangements or are involved in protein-protein 
interactions [29,31]. In comparison to synaptotagmin in the first three C2-domains of 
otoferlin several of the aspartate residues in the presumed Ca2+-binding site are 
missing (Table 1.4-1) [20]. In the C2A-domain only one aspartate residue is present, 
Ca2+-binding studies revealed that this first domain is not able to bind any Ca2+-ions 
[20,34]. The C2B-domain also contains only one aspartate residue and the C2C-domain 
contains three aspartate residues, according to predictions of the structure [20]. 
Thus, it was assumed that the second and third C2-domain of otoferlin are also not 
able to bind Ca2+-ions [20]. In contradiction to these predictions Ca2+-binding was 
experimentally shown for these domains [15], yet the question which additional 
amino acids beside the few present aspartate residues are involved in the 
Ca2+-coordination has still not been answered. In the last three C2-domains of 
otoferlin all predicted aspartate residues are present and the ability to bind Ca2+ was 
confirmed by isothermal titration calorimetry and fluorescence emission assays 
[20,35].  
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Table 1.4-1 Conservation of putative Ca2+-binding amino acids of the C2-domains. Shown is the 
comparison between synaptotagmin 1 and otoferlin. The numbers 1 to 5 indicate the amino acids 
which are located at presumed Ca2+-binding sites. Modified from Jiménez and Bashir, 2007.  
 
  1 2 3 4 5 
synaptotagmin C2A D D D D D 
 C2B D D D D E 
otoferlin C2A G D N S K 
 C2B N D S N T 
 C2C N D D D V 
 C2D D D D D D 
 C2E D D D D D 
 C2F D D D D D 
 
Further studies of the C2A-domain of synaptotagmin 1 revealed some additional 
amino acids involved in the binding of three Ca2+-ions. A serine residue and three 
backbone carbonyl groups were identified. Using several different NMR methods the 
influence of selected aspartates was analyzed. During these NMR-studies the Ca1-site 
(Figure 1.4–3) was identified as the high affinity binding site which is proposed to 
induce structural stability to the domain during Ca2+-binding.  
 
 
Figure 1.4–3 Overview of the Ca2+-coordinating aspartate residues in top loop 1 and 3 of the 
C2A-domain of synaptotagmin 1, modified from Ubach et al., 1998. The amino acids marked by a green 





In addition the binding of Ca2+ at this site should help to arrange the side chains of 
D172, D230 and D232 into the orientation required for the formation of the binding 
sites Ca2 and Ca3. The mutation of aspartate D178 into an asparagine disrupts the 
Ca1-binding site and showed a decrease in the affinity of Ca2 and Ca3. On the other 
hand in case of the mutations of D232 and D238 only the highest affinity site (Ca1) 
remains unaffected. The mutation of the S235 causes only the loss of the lowest 
affinity site (Ca3) [36].  
To date, a conformational change induced by Ca2+-binding was only reported for the 
piccolo C2A-domain [37]. In case of other C2-domains it was not observed that 
Ca2+-binding could induce serious changes in the overall conformation [32,38,39]. 
Simple locally Ca2+-induced structural changes have been postulated or observed for 
a few C2-domains [39,40]. In case of synaptotagmin 1 C2A the binding of a single 
Ca2+-ion causes little or no changes within the overall structure. Only rotations of 
some side chains were observed but no substantial backbone rearrangements 
[40,41].  
Relating to the overall arrangement of tandem C2-domains, only examples for Syt 1 
(PDB id: 2R83), Syt 3 (PDB id: 3HN8, 1DQV) and extended synaptotagmin-2 (Esyt 2, 
PDB id: 4P42, 4NPK, 4NPJ) are known. Their structural arrangements show distinct 
differences. The comparison of the Esyt 2 structure in absence and presence of Ca2+ 
revealed no structural changes (Figure 1.4–4, A)[42,43], whereas in case of Syt 3 two 
different structures were observed (Figure 1.4–4, B)[44,45]. The Esyt 2 C2-domains 
exist in a v-shaped structure and their Ca2+-binding sites are arranged in opposite 
directions [42,43]. In contrast, the C2-domains of Syt 3 do not show such an 
arrangement, neither in the absence nor in the presence of Ca2+. In addition, the top 
loop regions of the Syt 3 C2-domains face each other. In the presence of Ca2+ Syt 3 
shows a so called closed conformation while the unbound state is in an open 
conformation [44,45]. For Syt 1 C2AB only a Ca2+-unbound structure is known but the 
arrangement of these C2-domains shows another orientation to each other than the 






Figure 1.4–4 Conformation of tandem C2-domains of Esyt 2 and Syt 3.  
A The superposition of the Ca2+-bound (orange) and unbound (blue) state of Esyt 2 shows no distinct 
differences.  
B The comparison of the bound (green) and unbound (pink) conformation of Syt 3 shows that the 
structure is changed through Ca2+-binding.  
1.4.2 Structure of the otoferlin C2A-domain 
The structure of otoferlin C2A was solved by crystallography [34]. As predicted before 
[15] this domain was demonstrated not to be able to bind any Ca2+-ions. Former 
sequence analysis predicted that the first β-strand of the C2A-domain is missing [47]. 
In contrast to these expectations the found C2-domain forms an eight stranded 
antiparallel β-sandwich in a type II topology. In comparison to other C2-domains 
there are considerable differences in the Ca2+-binding region (CBR). The otoferlin top 
loop 1 is much shorter and not tilted (Figure 1.4–5). The formation of the loop 3 is 
similar to other C2-domains. Normally, loop 1 contains two of the five coordinating 
aspartate residues and the other three are located in loop 3. The structure-based 
sequence alignment of otoferlin C2A and synaptotagmin 1 C2A showed that only one 
of the expected aspartates is present in loop 1. The second aspartate would be located 
in the truncated region of the loop. Despite the similarity of loop 3 to other 
C2-domains the three aspartate residues for Ca2+-binding are missing. They are 
replaced by two neutral and one positively charged amino acids (Asn 68, Ser 70 and 
Lys 76). Additional Ca2+-binding assays, like isothermal titration calorimetry (ITC) 
and circular dichroism (CD), confirmed that the first C2-domain of otoferlin is not able 
to bind any Ca2+-ions. The insertion of four aspartate residues by mutation into the 
two top loops could not restore the Ca2+-binding ability of this domain.  
For several C2-domains it was reported that they are able to bind to lipids in a 
Ca2+-dependent or independent way. Furthermore, there are two possible binding 
locations for lipids on C2-domains. Either the lipids bind to the top loop region like 
Ca2+ or they can bind to the β-groove. The performance of flotation assays in absence 
Esyt 2          Syt 3 









Figure 1.4–5 Structure of the C2A-domain of otoferlin. Comparison of the otoferlin C2A-domain 
(orange) to the C2A-domain of synaptotagmin 1 (blue). The three Ca2+-ions coordinated by 
synaptotagmin are shown in yellow. Modified from Helfmann et al., 2011.  
A Overall structure of the C2A-domains of otoferlin and synaptotagmin with distinct differences in the 
top loop region.  
B Enlarged section of the Ca2+-binding region of both proteins. The top loop 1 of otoferlin is much 
shorter in comparison to the loop 1 of synaptotagmin and in addition only one of the aspartate 
residues (D18) for Ca2+-binding is present in both loops.  
 
1.4.3 Mutations in otoferlin 
Several point mutations can occur in proteins such as missense or nonsense 
mutations. Missense mutations appear if a base is exchanged and the sequence codes 
for a different amino acid. If the exchange of a base results in a premature stop codon 
which leads to a shorter version of the protein, the mutation is called “nonsense 
mutation”. Insertions and deletions of bases result in a frame shift which causes the 
coding of a different protein sequence, which results mostly in a premature stop. 
Several mutations are known for the protein otoferlin, some of them are 
loop 3 
K76 D238 












non-pathogenic mutations which were mostly found in the C2A-domain or in the 
linker regions (Figure 1.4–1) [28]. 
Most of the otoferlin mutations result in a homogeneous phenotype with severe to 
profound deafness (Figure 1.4–1) [48]. For some point mutations a rare short-term 
deafness was reported if the affected people became febrile and their body core 
temperature rose as little as 1 °C [49]. One in frame deletion and three missense 
mutations were so far identified to cause this form of deafness. These four known 
mutations are described in different sites of the protein (Figure 1.4–1) [17,50–52].  
One of these temperature sensitive deafness phenotypes results from a mutation 
called I515T which is located in the C2C-domain of the protein. At position 515 an 
isoleucine is replaced by a threonine. Until now it is still unknown which influence 
this mutation has on the structure or function of the C2-domain. According to the 
predictions of Jiménez and Bashir the affected position is located within the fifth 
β-strand of the C2-domain. Furthermore, this mutation is positioned two amino acids 
before the third aspartate, predicted to be involved in Ca2+-binding [20]. Thus, this 
mutation may influence the correct folding of the domain. Until now, the ability of the 
C2C-domain to bind Ca2+ is still under discussion, several contradictory findings were 
published [15,20,35,53]. If this domain is able to bind Ca2+ the mutation at position 
515 may influence as well the Ca2+-binding ability.  
A second point mutation in the C2C-domain of otoferlin is known to cause 
temperature sensitive deafness. This mutation affects a glycine at position 541 which 
is replaced by a serine [52]. According to structure predictions this point mutation is 
located in the last β-strand of the domain [20]. The change from this amino acid to a 
serine may have influence on the proper folding.  
Another mutation called pachanga (D1767G) was found in mice which leads to 
deafness [54]. In this mutation an aspartate residue was exchanged to a glycine. 
Jiménez and Bashir predicted that all Ferlin C2-domains likely adopt the type II 
topology. According to this assumption the mutation is positioned in a loop at the 
opposite end of the C2-domain to the Ca2+-binding region [20]. The effect of the 
pga-mutation is still unsettled but based on this position an influence on the 
secondary structure seems more likely than one in Ca2+-binding. A direct influence on 
the Ca2+-binding would only occur if the domain exists in the type II topology. In this 
case the pga mutation would be located in the top loop I. 
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1.5 Goal of the thesis 
During my experimental thesis work, I aimed to solve the structure of the otoferlin 
C2-domains trough crystallization of the protein. For this the expression and 
purification of both single C2-domains and fragments containing more than one 
domain had to be established. To clarify which of the C2-domains are able to bind Ca2+ 
it was planned to analyze different otoferlin fragments with MicroScale 
Thermophoresis (MST). Knowing that CaMKIIδ is able to interact with otoferlin, I 
tested whether the CaMKIIδ is capable to phosphorylate otoferlin in vitro. 
Furthermore, the effect of the determined sites within the Ca2+-binding process of the 
C2-domains had to be analyzed by MST. To evaluate the roles of the predicted 
aspartate residues in the binding pocket, which are responsible for Ca2+-binding 
within the C2F-domain, it was planned to mutate the positions and perform again MST 
measurements. Moreover selected mutations known to affect hearing should be 
tested by MST as well. A further goal of this work was the identification of possible 
interaction partners of otoferlin. Therefore pull-down experiments with mouse brain 
tissue should be performed followed by mass spectrometry analysis. Furthermore, 
the investigation of the thermal stability of otoferlin C2-domains using the thermal 
shift assay was as well an aim of this work.  
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2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Lab-equipment 
Adjustable pipets Eppendorf 
Agarose gel electrophoresis chamber Bio-Rad 
BioPhotometer Eppendorf 
Centrifuge 5415R Eppendorf 
Centrifuge Allegra 21R Beckman Coulter 
Centrifuge Avanti J-20 XPI Beckman Coulter 
Centrifuge Avanti J-30 I Beckman Coulter 
CFX 96 Real-Time System C1000 Thermal Cycler Bio-Rad 
Electrophoresis Power Supply EPS 301 Amersham pharmacia biotech 
Fine balance Sartorius 
Gel Doc 2000 Bio-Rad 
Incubator HT Multitron Infors 
Incubator Mytron Schütt 
Mircrofluidizer 110 S Microfluidics 
Monolith NT.LabelFree NanoTemper Technologies 
PCR-Whatman Biometra T personal Biometra 
pH-Meter Beckman Beckman 
Pipette Controller Accu-Jet Brand 
Platform Shaker Duomax 1030 Heidolf 
Rotor JA-20 Beckman Coulter 
Rotor JA-30.50 Ti Beckman Coulter 
Rotor JLA-8.1000 Beckman Coulter 
SDS-PAGE_System Hoefer miniVe Amersham Pharmacia Biotech 
Thermo Stat plus Eppendorf 
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2.1.2 Chromatography systems, columns and accessories 
In this work the chromatography system ÄKTA Prime (GE Healthcare) was used. The 
protein samples were loaded using 5, 50 or 150 ml superloops (GE Healthcare). The 
following columns were used. 
 
GSH sepharose 5 ml GE Healthcare/Macherey-Nagel 
GSH sepharose 15 ml GE Healthcare 
HisTrap 5 ml Ni-NTA sepharose GE Healthcare/Macherey-Nagel 
HiPrep Desalting 26/10 GE Healthcare 
Superdex 75 (26/60) GE Healthcare 
Superdex 200 (16/60) GE Healthcare 
Superdex 200 (26/60) GE Healthcare 
StrepTaction HP sepharose 5 ml GE Healthcare 
 
2.1.3 Kits 
peqGOLD Plasmid Miniprep Kit I Peqlab 
peqGOLD Cycle-Pure Kit Peqlab 
NucleoSpin Gel and PCR Clean-up Macherey-Nagel 
StarGate® Combi Entry Cloning Set IBA 
StarGate® Transfer Reagent Set IBA 
 
2.1.4 Size standards for proteins and DNA 
Prestained Protein Molecular Weight Marker ThermoScientific 
Protein Molecular Weight Marker ThermoScientific 
GeneRuler 1kb DNA Ladder ThermoScientific 
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2.1.5 Consumable material 
24 well crystallization plates Hampton Research 
96 well crystallization plates Hampton Research 
Amicon Ultra Centrifugal Filters Merck Millipore 
Crystal Clear Tape Henkel 
Falcon Tubes Greiner Bio-One 
Half micro cuvettes Sarstedt 
Monolith NT.LabelFree Standard Treated Capillaries NanoTemper Technologies 
Petri dishes 92 x 16 mm Sarstedt 
Pipet tips Sarstedt 
Reaction tubes (0.5 ml, 1.5 ml, 2 ml) Eppendorf 
Sterile Filter Merck Millipore 
 
2.1.6 Crystallization screens 
Ammonium sulfate suite Quiagen 
JBScreen Classic (1,2,4,5) Jena BioScience 
JBScreen Classic (6,7,8,10) Jena BioScience 
JBScreen Nuc-Pro HTS Jena BioScience 
JBScreen PACT++HTS Jena BioScience 
JCSG+ Suite Newman et al. (2005) 
MIDAS MD 1-59 (1 x and 0.5 x) Molecular Dimensions 
Morpheus  Molecular Dimensions 
Natrix HT Hampton Research 
PGA-LM HT 96 Molecular Dimensions 
ProPlex Radaev et al. (2006) 
 




All organic substances and fine chemicals were purchased from the companies 
AppliChem, Bio-Rad, Fluka, IBA, Merck, MWG Biotech, Oxoid, Roth or Sigma-Aldrich in 
the purity pro analysis. Generally, the provider with the lowest price was chosen. 
 
2.1.8 Plasmids 
Table 2.1-1 Plasmids used for recombinant protein expression. The restriction site cloning (RS) or 
overlap PCR (OP) of these protein fragments were performed and kindly provided by Dr. Sarah 
Helfmann (a) and Dr. Kirsten Reuter (b). 
Name Cloning method Oligonucleotides 
His6-C2AB (pET28a)a RS 1,2 
GST-C2B (pGEX-6P-3)a RS 3,4 
GST-C2C (pGEX-6P-3)a RS 5,6 
GST-C2E (pGEX-6P-3)a RS 7,8 
GST-C2F (pGEX-6P-3)a RS 9,10 
GST-pga-kurz (pGEX-6P-3)b OP 11-14 
 
Table 2.1-2 Plasmids used for recombinant protein expression. For cloning either the StarGate Cloning 
Kit (SG) or restriction site cloning protocol (RS) was used. The used oligonucleotides were ordered 
from Sigma Aldrich and listed in the appendix (see section 6). 1The C2F-phos-fragment was ordered as 
a synthetic gene and transferred into the GST-tag containing vector. 
Name Cloning method Oligonucleotides 
C2ABC-His6 (pPSG-IBA33) SG 15,16 
Strep-C2ABC-short (pPSG-IBA5) SG 15,17 
His6-C2DEF (pET28a) RS 18,19 
Dynamin 1-Strep (pPSG-IBA3) SG 20,21 
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Table 2.1-3 Different mutations were inserted in the existing protein fragments. This was either 
performed using the QuikChange Manual (QC) or by overlap extension PCR (OP). The used 
oligonucleotides were ordered from Sigma Aldrich and listed in the appendix (see section 6). 
Name Cloning method Oligonucleotides 
C2ABC-I515T-His6 (pPSG-IBA33) QC 22,23 
C2ABC-G541S-His6 (pPSG-IBA33) QC 24,25 
GST-C2C-phos (pGEX-6P-3) QC 26,27 
GST-C2F-D1N (pGEX-6P-3) QC 28,29 
GST-C2F-D2,3N (pGEX-6P-3) OP 30-33 
GST-C2F-D1,2,3N (pGEX-6P-3) OP 30-35 
GST-C2F-D4N (pGEX-6P-3) QC 36,37 
GST-C2F-E1804del (pGEX-6P-3) QC 38,39 
 
2.1.9 Organisms 
The used E. coli strains SoluBL21 (DE3), Rosetta 2 (DE3) and XL1 Blue were part of 
the Department for Molecular Structural Biology, Georg-August University Göttingen. 
The E. coli TOP10 cells were purchased from IBA.  
2.1.10 Enzymes and inhibitors 
ALP-Protease inhibitor mix MSB, University Göttingen 
Phusion-DNA Polymerase ThermoScientific 
PreScission-Protease GE Healthcare 
Restriction Enzymes ThermoScientific 
T4-DNA Ligase ThermoScientific 
Shrimp alkaline phosphatase (SAP) ThermoScientific 
Calmodulin-dependent kinase II delta (CaMKIIδ) Life technologies 
 
2.1.11 Antibiotics with working concentrations 
Ampicillin (100 µg/ml) AppliChem 
Kanamycin (50 µg/ml) Roth 
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2.1.12 Cell media 
 
2YT-medium   2YT-agar  
1 % (w/v)  Tryptone  500 ml 2YT-medium 
1 % (w/v) Yeast extract  1.5 % (w/v) agar 
1 % (w/v) NaCl    
 
 
1 x ZY-medium   1000 x MgSO4  
1 % (w/v) Tryptone  2 M  MgSO4 x 7 H2O 
0.5 % (w/v) Yeast extract    
     
50 x M   5000 x Trace elements 
1.25 M  K2HPO4  50 mM  FeCl3 
1.25 M  NaH2PO4 x H2O  20 mM CaCl2 
2.5 M NH4Cl  10 mM MnCl2 
0.25 M Na2SO4 x 10 H2O  50 mM ZnSO4 
   2 mM CoCl2 
50 x 5052   2 mM CuCl2 
25 % (v/v) Glycerol  2 mM NiSO4 
2.5 % (w/v) Glucose  2 mM Na2MoO4 
10 % (w/v) α-Lactose  2 mM Na2SeO4 
   2 mM H3BO4 
     
Mixture of 1 l ZYM-5052     
1 l 1 x ZY    
20 ml 50 x M    
20 ml 50 x 5052    
1 ml 1000 x MgSO4    
200 µl 5000 x Trace elements    




2.2.1 Molecular biological methods 
2.2.1.1 Molecular cloning 
2.2.1.1.1 Restriction site based cloning 
For restriction site cloning the DNA was amplified with forward and reverse 
oligonucleotides containing the necessary restriction sites. After the polymerase 
chain reaction (PCR) the sample was purified via the peqGOLD Cycle-Pure Kit. The 
target-DNA and plasmid-DNA were digested using the appropriate restriction 
enzymes. After 1 h of incubation at 37 °C the enzymes were inactivated during a 
heating step at 80 °C for 20 min. For dephosphorylation of the digested vector 
0.01 units per pmol DNA of the Shrimp alkaline phosphatase (SAP, ThermoScientific) 
was added and incubated for 1 h at 37 °C followed by an inactivation step at 80 °C for 
20 min.  
To ligate the two components, 200 ng of the vector were used and mixed with a 
5-fold molar excess of insert-DNA. Additionally, 1 µl of T4-DNA ligase 
(ThermoScientific), 1 µl of 10 mM ATP and 1 µl of the supplemented 10 x T4 ligation 
buffer (ThermoScientific) were added. The ligation reaction took place over night at 
16 °C. Afterwards the entire sample was transformed into E. coli XL1-Blue cells and 
plated on an agar plate with the appropriate antibiotics. 
2.2.1.1.2 StarGate 
In the first step of the StarGate cloning the DNA was extended at the 3’- and 5’-end 
with a StarCombinase site. This was done during PCR with appropriate 
oligonucleotides. The obtained PCR fragment was inserted into the pENTRY-IBA10 
vector using special StarGate solutions (StarGate instruction manual February 2011).  
The mixture was incubated for 1 h at 30 °C and transformed into chemically 
competent E. coli TOP10 cells. A control digestion with XbaI and HindIII verified the 
plasmid DNA of the colonies. The DNA sample was sequenced for positive results to 
confirm the sample correctness. 
The correct target-DNA was transferred from the donor vector (pENTRY-IBA10) into 
the acceptor vector of choice by using special transfer reagents according to the 
manufacturer’s protocol. The sample was incubated for 1 h at 30 °C and transformed 
into E. coli TOP10 cells.  
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Again, a digestion reaction with XbaI and HindIII served to control the successful 
transfer.  
2.2.1.2 Polymerase chain reaction (PCR) 
The polymerase chain reaction allows the selective amplification of a specific DNA 
sequence. Defining this specific sequence requires oligonucleotides with a length of 
20-30 bp which have to be complementary to the 3’- and 5’-end of the amplification 
region. A DNA-polymerase extends the oligonucleotide sequences and creates a new 
complementary DNA strand. 
 
Standard PCR mixture 
200 ng Template-DNA 
10 mM dNTPs 
10 pmol forward primer 
10 pmol reverse primer 
10 µl 5xHF buffer 
0.5 µl Phusion polymerase (ThermoScientific) 
Add to 50 µl ddH2O 
  
 
Standard PCR program    
Initial denaturation 96 °C 120 s  
Denaturation 96 °C 30 s  
Annealing of oligonucleotides x °C 30 s × 25-30 
Elongation 72 °C 15 s/kb  
Final elongation 72 °C 300 s  
 
For the specific annealing temperature (x) a value of 3-5 °C lower than the melting 
temperature of both oligonucleotides is recommended. The obtained PCR result was 
analyzed with agarose gel electrophoresis and purified using the peqGOLD MicroSpin 
Cycle-Pure Kit (PEQLAB).  
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2.2.1.3 Agarose gel electrophoresis 
Agarose gel electrophoresis allows the separation of DNA fragments according to 
their size. Within an electrical field the DNA moves towards the anode because of the 
negatively charged phosphate backbone.  
For gel preparation 1 % (w/v) agarose was added into 1 x TAE buffer and boiled in 
the microwave. The clear solution was mixed with GelRed (1:10000, biotinum, VWR) 
and poured into a gel chamber with a comb. The samples were mixed with 6 x loading 
dye and loaded on the cold and solid agarose gel. The gel was run with 125 V until the 
required separation was reached.  
The DNA fragments were analyzed under UV light (254 nm) with the GelDoc system 
(Bio-Rad). 
 
DNA loading dye (6x)  TAE buffer (50x) 
10 mM Tris/HCl pH 7.6  2 M Tris acetate pH 8.0 
0.03 % Bromphenole blue  50 mM EDTA 
0.03 % Xylene cyanol ff    
60 %  Glycerol    
60 mM  EDTA    
 
2.2.1.4 DNA-Extraction from agarose Gels 
To extract DNA from an agarose gel, the appropriate band was cut out of the gel and 
purified using the NucleoSpin Gel and PCR Clean-up Kit (Machery-Nagel) following 
the manufacturer’s recommendations. 
2.2.1.5 Preparation of plasmid DNA 
The preparation of plasmid DNA from overnight cultures was performed with the 
peqGOLD MiniPrep Kit 1 according to the manufacturer’s protocol. 
2.2.1.6 Determination of the DNA concentration 
The bio photometer of Eppendorf was used to determine the DNA concentrations 
through absorption at 260 nm. All DNA samples were solved in water. 
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2.2.1.7 Restriction enzyme digest 
Restriction enzymes are able to cut specific sequences. The restriction enzymes of 
choice and the appropriate buffer were added to the reaction mixture and incubated 
for 1 h at 37 °C. To inactivate the enzymes the mixture was heated at 80 °C for 20 min.  
2.2.1.8 DNA sequencing 
The plasmid DNA was send to Seqlab, GATC or the sequencing service of the Pieler 
department for sequencing. The data was analyzed afterwards by using Chromas 
(Version 1.45) and ApE (A plasmid Editor v1.17) to verify the samples. 
2.2.1.9 Mutagenesis 
To generate small mutations in the gene of interest site-directed mutagenesis was 
performed. Oligonucleotides were designed that contain 15 nucleotides on the 5’-end 
and the 3’-end flanking the mutated site. Complementary oligonucleotides were used 
to amplify both strands of a plasmid. The following addition of the endonuclease DpnI 
digested the methylated starting-DNA. The mutated DNA was transformed into E.  coli 
XL1 blue competent cells. After a consequent plasmid preparation the DNA was 
sequenced to confirm the inserted mutation. 
 
Standard mutagenesis mixture 
50 ng Template-DNA 
10 mM dNTPs 
10 pmol forward primer 
10 pmol reverse primer 
10 µl 5 x HF buffer 
0.5 µl Phusion polymerase 
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Standard mutagenesis PCR program 
Initial denaturation 96 °C 120 s  
Denaturation 96 °C 30 s  
Annealing of oligonucleotides 55 °C 30 s × 25-30 
Elongation 68 °C y s  
Final elongation 68 °C 300 s  
 
The elongation time (y) depends on the final length of the plasmid. 
 
2.2.1.10 Site directed mutagenesis by overlap PCR 
For this method two pairs of oligonucleotides are needed. One pair contain the 
5’-forward oligonucleotide which is necessary for the amplification of DNA between 
the 5’-end and the mutation region and a mutation containing oligonucleotide. The 
second pair consist of a 3’-reverse oligonucleotide and the complementary mutation 
containing oligonucleotide. The 5’- and 3’-oligonucleotides also carry a restriction site 
which allows the cloning into the vector of choice. Both oligonucleotides pairs are 
used in two separate amplification reactions. The obtained fragments from these 
reactions contain an overlapping sequence including the inserted mutation. In the 
next step both obtained fragments were mixed and two cycles of annealing and 
elongation were performed. The annealing took place at 37 °C for 5 min followed by 
an elongation step at 71 °C for 5 min. Afterwards the 5’- and 3’-oligonucleotides were 
added and a PCR with 20 cycles was done to generate the product. In the following 
step the gained fragment was digested by the appropriate restriction enzymes and 
transferred into the vector (see section 2.2.1.1.1).  
 
2.2.1.11 Transformation 
200 ng of plasmid DNA were added to chemically competent cells to transform the 
target DNA into E. coli cells. The solution was incubated on ice for 30 min, followed by 
a heat-shock step at 42 °C for 45 s and incubation on ice for 2 min. After this 
incubation 900 µl of 2xYT-medium were added to the cells. A further incubation step 
was conducted for 45 min at 37 °C. The solution was either transferred into an 
overnight culture (50 ml 2xYT-medium) with appropriate antibiotics or was slowly 
centrifuged at 1500 x g for 3 min; the pellet was resuspended in approximately 100 µl 
2 Materials and methods 
2.2 Methods 
26 
residual 2xYT medium and plated on agar plates supplemented with the 
corresponding antibiotics. 
2.2.1.12 Generation of chemical competent E. coli cells 
A 50 ml overnight culture was inoculated with the appropriate E. coli strain and 
incubated at 37 °C. In the next step, a 500 ml 2xYT-culture was inoculated with the 
preculture in a ratio of 1:500. When an OD600 of 0,6-0,8 was reached, the cells were 
harvested at 2550 x g for 10 min at 4 °C. The pellet was resuspended in 125 ml of 
100 mM Mg2+-chloride followed by a centrifugation step for 10 min at 1560 x g and 
4 °C. After removing the supernatant the pellet was resuspended in 250 ml of 100 mM 
Ca2+ chloride and again centrifuged as before. The final pellet was dissolved in 5 ml of 
100 mM Ca2+-chloride with 15 % glycerol and aliquots of 50 µl were frozen in liquid 
nitrogen and stored at -80 °C. 
2.2.2 Proteinbiochemical methods 
2.2.2.1 Recombinant expression of proteins in E. coli 
2.2.2.1.1 Induction with IPTG in 2xYT-medium 
The DNA of choice was transformed into SoLuBL21 cells. 500 ml of 2YT-medium were 
inoculated with the preculture in a ratio of 1:100 and grew at 30 °C until an OD600 of 
1.2 was reached. After the addition of 500 ml, 4 °C precooled 2YT-medium IPTG was 
added to a final concentration of 0.5 mM. The incubation temperature was changed to 
16 °C and the cultures were harvested 16-20 h after induction.  
2.2.2.1.2 Autoinduction 
Rosetta 2 (DE3) cells were used to express a protein with the autoinduction system. 
500 ml of ZY-medium were mixed with a 50xM solution, a 50x5052 solution, 
Mg2+-sulfate and trace elements (see section 2.1.11). The expression culture was 
inoculated with preculture (1:100) and incubated at 16 °C for 72 h.  
2.2.2.2 Cell harvest and lysis 
The cell cultures were harvested using centrifugation (20 min at 5750 x g). The 
obtained cell pellets were frozen at -20 °C for storage or lysed for protein purification. 
For cell lysis the pellet was resuspended in lysis buffer; for 1 g cell pellet 5 ml buffer 
were used. The cells were lysed using the Microfluidizer 110 S followed by a 
centrifugation step for 40 min at 40000 x g to obtain a clear supernatant. The solution 
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containing the protein of interest was filtrated by using a 0.2 µm filter and loaded 
onto the appropriate affinity column. 
2.2.2.3 Inclusion bodies 
Protein that turned out to be completely insoluble after expression in E. coli was 
purified from inclusion bodies. The harvested cells were resuspended in lysis buffer 
and disintegrated using the Mircofluidizer followed by centrifugation (45 min at 
40000 x g). The obtained supernatant was removed and the pellet resolved in PBS 
buffer containing 2 mM DTT and 1 % Triton-X. After the next centrifugation step the 
pellet was washed twice using PBS buffer with DTT followed by centrifugation. The 
pellet was solved in lysis buffer containing 8 M UREA and incubated rotating for 1 h at 
4 °C. After incubation the sample was again centrifuged and the supernatant was 
loaded onto the appropriate affinity column. 
2.2.2.4 Protein purification 
Different affinity columns and gel filtration columns were used to purify the protein. 
All used columns were stored in 20 % (v/v) ethanol and washed with desalted H2O 
and buffer before usage. If necessary the column was regenerated after usage by 
washing with desalted H2O and 20 % (v/v) ethanol.  
2.2.2.4.1 Hexahistidine affinity chromatography 
Proteins containing a C- or N-terminal His6-tag were purified using Ni-NTA sepharose 
columns. The polyhistidine tag of the protein interacts with the immobilized Ni2+-ions 
on the column. The obtained supernatant after centrifugation was loaded on the 
column using a superloop. After binding the protein to the sepharose, the column was 
washed with lysis buffer containing 10 mM imidazole to eliminate impurities. The 
elution of the protein was performed by using a gradient of the imidazol 
concentration in a certain volume (50-250 ml) which was chosen in relation to the 
behavior of the protein. The regeneration of the column occurred with 0.5 M sodium 
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Lysis buffer   Elution buffer  
75 mM HEPES pH 7.4  75 mM HEPES pH 7.4 
300 mM NaCl  300 mM NaCl 
1 mM PMSF  300-500 mM Imidazole 
ALP-protease inhibitor mix    
10-20 mM Imidazole    
 
2.2.2.4.2 Glutathione-S-Transferase affinity chromatography 
For the purification of GST-tagged proteins Glutathione-sepharose 4B columns were 
used. The GST fusion protein adheres to glutathione which is immobilized on the 
matrix of the column. Proteins without this tag are not able to bind the matrix and are 
removed during the following washing steps. The target protein was eluted by 
washing the column with elution buffer which contained 30 mM reduced glutathione. 
The obtained samples were analyzed using SDS-PAGE. 
 
Lysis buffer   Elution buffer  
75 mM  HEPES pH 7.4  75 mM HEPES pH 7.4 
300 mM NaCl  300 mM NaCl 
1 mM PMSF  30 mM  reduced glutathione 
ALP-protease inhibitor mix    
 
2.2.2.4.3 StrepTactin affinity chromatography 
The binding ability of the Strep-tag and StrepTactin which is immobilized on the 
column matrix was used to purify Strep-tagged proteins. After loading the protein on 
the column a short wash step was performed. Then the protein was eluted with an 
elution buffer containing 2.5 mM desthiobiotin. After usage the column had to be 
regenerated by washing with 2 column volumes 0.5 M sodium hydroxide. The 
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Lysis buffer   Elution buffer  
75 mM HEPES pH 7.4  75 mM HEPES pH 7.4 
300 mM NaCl  300 mM NaCl 
1 mM PMSF  2.5 mM desthiobiotin 
ALP-protease inhibitor mix    
 
2.2.2.4.4 Desalting of protein solutions 
The HiPrep Desalting 26/10 column was used to exchange the buffer or to desalt a 
protein solution. Small molecules will enter the Sephadex G-25 Superfine beads 
whereas large molecules directly pass the column and elute first. The maximum 
sample volume which can be loaded onto this column is 12.5 ml.  
2.2.2.4.5 Size exclusion chromatography 
During the size exclusion chromatography the proteins are separated according to 
their size. Smaller molecules are able to enter deeper into the pores of the matrix than 
big molecules, which means that proteins with a higher molecular weight can migrate 
faster through the column.  
The column was equilibrated with a buffer and the concentrated protein sample was 
loaded. SDS gel electrophoresis was used to analyze the obtained samples. 
 
Size exclusion buffer 
10 mM HEPES pH 7.4 
150 mM NaCl 
 
2.2.2.5 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
To separate and analyze proteins due to their size SDS polyacrylamide gel 
electrophoresis was performed. Four sets of glass and ceramic plates with spacers 
were packed into the Hoefer miniVE system for the gel preparation. The chamber was 
filled to 80 % with a separating gel solution and covered with isopropyl alcohol. After 
the polymerization of the resolving gel the 2-propanol was removed and the stacking 
gel solution was added. Inserted combs created reservoirs for the protein samples. 
After the final polymerization the gels were directly used or stored at 4 °C. 
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Depending on the size of the protein different acrylamide concentrations were used 
to generate 5 %, 7.5 %, 10 %, 12.5 % or 15 % resolving gels. 
 
Resolving Gel  
7.5-15 % (w/v) Acrylamide/Bisacrylamide (37.5:1) 
0.375 M Tris/HCl pH 8.8 
0.1 % (w/v) SDS 
0.1 % (v/v) TEMED 
0.05 % (w/v) APS 
 
Stacking Gel 
5 % (w/v) Acrylamide/Bisacrylamide (37.5:1) 
0.125 M  Tris/HCl pH 6.8 
0.1 % (w/v) SDS 
0.1 % (v/v) TEMED 
0.05 % (w/v) APS 
 
The protein samples were mixed with 2xLaemmli sample buffer [55] and heated for 
5 min at 95 °C. After loading the samples into the reservoirs the gel was run at 35 mA 
for 75 min. The finished gel was incubated with a staining solution in order to 
visualize the protein bands. H2O was used for destaining.  
The destained gels were digitized using a scanner (Canon CanoScan 5600F). 
 
2xLaemmli sample buffer 
62.5 mM Tris/HCl pH 6.8 
70 mM SDS 
55 % (v/v) Glycerol 
0.1 % (w/v) Bromphenol blue 
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Running buffer  
25 mM  Tris/HCl 
192 mM Glycine 
0.1 % (w/v) SDS 
 
Staining solution  
10 % (v/v) Ethanol 
5 % (v/v) Acetic acid 
0.002 % (w/v) Coomassie Brilliant Blue G/R250 
 
2.2.2.6 Proteolytic digestion with PreScission protease 
To remove the GST-tag from the corresponding C2-domain, PreScisson protease 
(GE Healthcare) was added in a ratio 1:100 and the solution was incubated overnight 
at 4 °C. To confirm a successful cleavage of the fusion-protein, an SDS-PAGE was 
performed containing an undigested and a digested sample. 
2.2.2.7 Concentrating protein solutions 
Amicon concentrators (Merck Millipore) were used for protein concentration. These 
concentrators contain membranes with a specific molecular weight cut-off. The 
chosen cut-off depends on the size of the protein. During centrifugation at 4000xg 
and 4 °C small molecules like H2O or ions can pass the membrane while the 
target-protein remains in the upper part of the concentrator. This leads to an 
increased protein concentration.  
2.2.2.8 Determination of the protein concentration 
The protein concentration was measured using the Bradford reagent. The principle of 
this measurement is based on the change in absorption of Coomassie Brilliant Blue 
G-250 during the binding to proteins.  
980 µl of the Bradford solution together with 20 µl ddH2O or buffer were used for the 
blank value. To measure the concentration 20 µl of the protein solution were mixed 
with 980 µl Bradford solution and measured at a wavelength of 595 nm.  
2 Materials and methods 
2.2 Methods 
32 
2.2.2.9 Phosphorylation with CaMKIIδ and inhibition using CBD 
For in vitro phosphorylation the two otoferlin fragments (C2ABC and C2DEF, 
21.49 pmol each) in assay buffer were incubated with the same amount of 
Calmodulin-dependent kinase II delta (CaMKIIδ) for 5 min at 30 °C. The reaction was 
stopped by adding 2xLaemmli buffer and heating for 5 min at 30 °C. To test if the 
Calmodulin binding domain (CBD, Calbiochem, IC50 = 52 nM) is able to inhibit the 
phosphorylation of otoferlin, the CBD was incubated together with CaMKIIδ in the 
reaction-buffer without calmodulin. After a 5 min incubation at 30 °C calmodulin and 
otoferlin were added and incubated for another 5 min at 30 °C. This reaction was 
stopped by adding 2xLaemmli buffer and heating the sample at 95 °C for 5 min. The 
CBD was used in a 10-fold excess of the IC50 value. The samples were loaded onto an 
SDS gel. These gels were sent to our collaborators who analyzed the bands by mass 
spectrometry in the lab of C. Adams, Stanford, USA. 
 
2.2.2.10 Screen for protein-protein-interactions using pull-down assays 
To look for possible interaction partners of the C2ABC-fragment of otoferlin 
pull-down assays were performed. In the first experiment Ni-NTA sepharose beads 
were used. The His6-tagged C2ABC-fragment (2 nmol each) was incubated with 
appropriate beads for 8 h at 4 °C to immobilize the proteins onto the beads. Several 
careful washing steps were carried out to get rid of unbound proteins. After these 
washing steps 1 ml lysed mouse brain, which was provided from Sunit Mandat 
(Urlaub-Lab, MPI-bpc, Göttingen), was added and incubated for 4 h or overnight. The 
beads were washed again to remove the free interaction partner. All incubation and 
washing steps were performed at 4 °C or on ice. For the analysis the beads-samples 
were loaded on an SDS-PAGE, digested and analyzed with mass spectrometry.  
Due to the fact that sometimes Ni-beads bound unspecific proteins the same 
experiment was performed using a shorter C2ABC-fragment containing a Strep-tag 
which was bound to Strep-beads. The following steps were performed as described 
before. 
 
Wash buffer  
10 mM HEPES pH 7.4 
150 mM NaCl 
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In a second pull-down experiment epoxy-activated Eupergit beads were used which 
react with the amino- and thiol-groups of the protein. Before usage the beads were 
washed with water twice and treated with full power in an ultrasonic bath pulsed for 
about 2 min. afterwards the beads were centrifuged at 1300xg for 6 min. The 
supernatant was removed and the protein solution added (15 nmol) followed by an 
incubation step at 4°C for 8 h. After the incubation the supernatant was removed and 
the beads were washed with protein buffer. To block all the remaining binding sides 
on the beads, 1 M glycine was added to the beads and incubated overnight at 4 °C. To 
prepare the beads for further use, the supernatant was discarded and the beads were 
washed alternating with wash buffer 1 and wash buffer 2 three times each. The beads 
were split up into 10 µl aliquots and stored at -80 °C. In this experiment mouse 
synaptosomes were used for interaction partner screening. The synaptosomes were 
prepared from Sunit Mandat using a published protocol [56]. Different detergents 
(see below) were added to the synaptosomes and incubated for 1 h at 4 °C. The lysed 
synaptosomes were incubated with the prepared protein containing beads overnight 
at 4 °C. The samples were rotated during all the incubation steps. After removing the 
supernatant the beads were washed with protein buffer for several times and 
analyzed using mass spectrometry, the latter by Sunit Mandat in the lab of Henning 
Urlaub. 
 
Protein buffer  
10 mM HEPES pH 7.4 
150 mM NaCl 
 
Wash buffer 1   Wash buffer 2 
100 mM Sodium acetate pH 4.7  100 mM Tris/HCl pH 8.0 
500 mM NaCl  500 mM NaCl 
 
beads   
His PurTM Ni-NTA Resin ThermoScientific His-tag 
Strep-Tactin® Superflow® IBA Strep-tag 
Eupergit C17 methacrylate 
microbeads 
Röhm Pharmaceuticals Amino binding 
 




Lauryl sarcosine (LS) Sigma-Aldrich 
Sodium dodecyl sulfate (SDS) Carl Roth 
Octyl glucopyranoside (OGP) Sigma-Aldrich 
Complexiolyte (COM) Logopharm GmbH 
Dodecyl maltoside (DDM) Sigma-Aldrich 
 
2.2.2.11 Thermal shift assay 
To get information about the stability of the different C2-domains thermal shift assays 
were performed (Bio-Rad C1000/CFX96) to obtain possible melting temperatures. 
The proteins of interest were mixed with a fluorescent dye (Sypro®Orange, 1:1000) 
and heated in small steps. At a specific temperature the protein unfolds and the 
fluorescent dye can bind to the hydrophobic patches of the protein. In this work 
single C2-domains and fragments containing up to three C2-domains were used. The 
protein fragments were measured alone or in the presence of other C2-domains. Each 
experiment was performed in the presence and absence of Ca2+ (200 µM). A protein 
concentration of 100 pmol was used; the second tested fragment was added in a 1:1 
ration. The sample solution was pipetted into a 96-well plate and centrifuged (10 min, 
1500 xg). For the measurement a temperature profile from 20-95 °C was used, the 
temperature was increased 1 °C per step (30 s). For the data analysis MaxStAF and 
Origin Pro 8.5G were used. 
2.2.2.12 Dissociation constant determination using MicroScale 
Thermophoresis 
To get information about the Ca2+-binding ability of otoferlin C2-domains, MircoScale 
Thermophoresis was performed. In this method the intrinsic tryptophan fluorescence 
of the molecule of interest is used for detection. When performing a MST experiment, 
a microscopic temperature gradient is induced by an infrared laser, and the directed 
movement of molecules is detected and quantified. Any binding event or 
conformational rearrangement leads to changes in the thermophoretic movement 
caused by changes in the hydration shell, size or charge of the molecule. By means of 
these changes it is possible to determine specific KD values. 
The protein was adjusted to a defined concentration in size exclusion buffer (see 
section 2.2.2.4.5) with 0.1 % Tween. The Ca2+-chloride was dissolved in the same 
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buffer as the protein and a series of 16 1:2 dilutions was prepared with the identical 
buffer, producing a ligand concentration ranging from 400 mM to 1.2 µM. For the 
thermophoresis measurements each ligand dilution was mixed with the same volume 
of the tryptophan containing component, which leads to a final protein concentration 
of 1 µM to 4 µM and final Ca2+-concentrations of 200 mM to 0.6 µM.  
The samples were loaded in Monolith NT.LabelFree standard treated capillaries 
(NanoTemper Technologies GmbH). The thermophoresis was measured using the 
NT.LabelFree instrument (NanoTemper Technologies GmbH) at a constant 
temperature of 22 °C with 5 s/30 s/5 s laser off/on/off times. The instrument 
parameters were adjusted with 5 % LED power and 20 % MST power. Data sets of 
three independently pipetted measurements were analyzed using the temperature 
jump (T-jump) signal. The T-jump shows sensitive changes which are in close 
proximity to the tryptophan that is used for detection. These changes can result from 
a direct binding event or can be induced by a conformational change. The 
thermophoresis signal on the other hand provides information of the overall 




3.1 Protein fragments 
36 
3 RESULTS 
3.1 Protein fragments 
One goal of this work was to express and purify different single C2-domains or 
combinations of C2-domains from E. coli for crystallization and interaction studies.  
Table 3.1-1 List of purified otoferlin fragments. Length and mass are given in number of amino acids 
and kDa. N (N-terminal) and C (C-terminal) mark the position of the tag. Fragments marked with a and 
b were kindly provided by Dr. Sarah Helfmann (a) and Dr. Kirsten Reuter (b). The numbers at the 
fragment name display the organism and the accession-number: 1 (mus musculus NP_001093865), 2 
(rattus norvegicus NP_001263649), 3 (mus musculus NP_034195.2). 
Name Amino acids Mol. mass (kDa) Affinity tag 
C2ABa,1 1-433 48.2 His6-tag (N) 
C2ABC1 1-616 69.8 His6-tag (C) 
C2ABC-I515T1 1-616 69.8 His6-tag (C) 
C2ABC-short1 1-581 66.9 Strep-tag (N) 
C2Ba,2 217-414 22.3 GST-tag (N) 
C2Ca,2 410-616 23.4 GST-tag (N) 
C2C-phos2 410-616 23.4 GST-tag (N) 
C2Ea,2 1435-1658 25.6 GST-tag (N) 
C2Fa,2 1695-1934 28.1 GST-tag (N) 
C2F-phos1 1695-1934 28.0 GST-tag (N) 
C2F-D1N2 1695-1934 27.9 GST-tag (N) 
C2F-D2,3N2 1695-1934 27.9 GST-tag (N) 
C2F-D1,2,3N2 1695-1934 28.0 GST-tag (N) 
C2F-D4N 1695-1934 28.0 GST-tag (N) 
C2F-pgab,2 1699-1934 27.2 GST-tag (N) 
C2F-E1804del2 1695-1934 27.8 GST-tag (N) 
C2DEF1 908-1932 117.9 GST-tag (N) 
Dynamin 13 1-752 87.5 Strep-tag (C) 
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In Table 3.1-1 all proteins are shown which are described in this work. Different 
protein fragments containing one to three C2-domains were used. Information about 
the fragment length, molecular mass and the used affinity tag are given in the table.  
3.2 Purification of His6-C2AB 
The C2AB-fragment of otoferlin was cloned into the pET28a vector. The His6-tagged 
protein was overexpressed at 30 °C in E. coli SoluBL21 cells. After induction with 
IPTG the temperature was changed to 16 °C and the cells were harvested 16 h after 
induction. The cells were lysed with a buffer (see section 2.2.2.4.1) containing 10 mM 
imidazole. The obtained supernatant after centrifugation was loaded on to 5 ml 
His-Trap-columns (GE Healthcare). The eluted protein was concentrated and a S200 
(16/60) size exclusion chromatography (Figure 3.2–1) was performed. Selected 
fractions were analyzed by SDS-PAGE.  
 
Figure 3.2–1 Size exclusion chromatography of His6-C2AB.  
A The UV absorption at 280 nm in the chromatogram is depicted as a blue line which is plotted against 
the elution volume and the fraction numbers are shown in red. The elution maximum at 70 ml 
corresponds to the His6-C2AB monomer. 
B The 12.5 % coomassie-stained SDS-PAGE gel of His6-C2AB contains selected fractions of the 
purification. M indicates the molecular weight marker in kDa and the numbers refer to the fractions of 
the size exclusion chromatography. The target protein is marked by an arrow. 
3.3 Purification of C2ABC-His6 
The C2ABC-fragment was cloned into the pPSG-IBA33 vector using the StarGate 
cloning system and overexpressed in E. coli BL21 cells. The cultures were harvested 
20 h after induction with IPTG. The obtained supernatant after cell lysis was loaded 
on a His-Trap and the protein of interest was eluted using an imidazole gradient. The 
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pooled protein fractions were concentrated and a S200 (16/60) size exclusion 
chromatography (Figure 3.3–1) was performed. Selected fractions were analyzed by 
SDS-PAGE. 
 
Figure 3.3–1 Size exclusion chromatography of C2ABC-His6.  
A The UV absorption at 280 nm in the chromatogram is depicted as a blue line which is plotted against 
the elution volume and the fraction numbers are shown in red. There is an elution maximum at 57 ml 
corresponding to the C2ABC-fragment.  
B The 12.5 % coomassie-stained SDS-PAGE gel of C2ABC-His6 contains selected samples of the 
purification. M indicates the molecular weight marker in kDa and the numbers refer to the fractions of 
the size exclusion chromatography. The target protein is marked by an arrow. For further experiments 
the combined fractions 13 to 15 were used. 
3.4 Purification of I515T-His6 
The I515T is an otoferlin mutation which leads to temperate sensitive deafness [51]. 
The mutation was subcloned into the C2ABC-His6-fragment using the QuikChange 
protocol. At position 515 an isoleucine was replaced by a threonine, this mutation is 
located in the C2C-domain of the protein. The expression and purification protocol 
was the same as for the C2ABC-His6-fragment. 
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Figure 3.4–1 Size exclusion chromatography of I515T-His6.  
A The blue line displays the UV absorption at 280 nm which is plotted against the elution volume. The 
fraction numbers are shown in red. The elution maximum at 55 ml corresponds to the I515T-fragment.  
B The 12.5 % coomassie-stained SDS-PAGE gel of I515T-His6 contains selected samples of the 
purification. M indicates the molecular weight marker in kDa and the numbers refer to the fractions of 
the size exclusion chromatography. The target protein is marked by an arrow. 
3.5 Purification of Strep-C2ABC-short 
 
Figure 3.5–1 Strep-column chromatography of Strep-C2ABC-short.  
A The UV absorption at 280 nm in the chromatogram is depicted as a blue line which is plotted against 
the elution volume and the fraction numbers are shown in red. There is an elution maximum at 170 ml 
corresponding to the Strep-C2ABC-fragment.  
B The 12.5 % coomassie-stained SDS-PAGE gel of Strep-C2ABC-short contains selected samples of the 
purification. M indicates the molecular weight marker in kDa, G is a sample after cell lysis. S 
(supernatant) and P (pellet) are samples after centrifugation. The numbers refer to the fractions of the 
Strep-column chromatogram. Marked by an arrow the target protein is shown. 
 
Using the StarGate cloning system, a shorter variant of the C2ABC-fragment was 
incorporated into the Strep-tag containing pPSG-IBA5 vector. The protein was 
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expressed in E. coli SoluBL21 cells, induced with IPTG and harvested 20 h after 
induction. After cell lysis and centrifugation, the obtained supernatant was loaded 
onto a Strep-column (Figure 3.5–1). Desthiobiotin was used to elute the protein from 
the column. Selected fractions were analyzed by SDS-PAGE.  
3.6 Purification of GST-C2B 
The C2B-fragment of the protein otoferlin was cloned into the pGEX-6P-3 vector and 
overexpressed in E. coli SoluBL21 cells. 20 h after induction with IPTG, the cells were 
harvested and lysed using the microfluidizer system. The obtained supernatant from 
centrifugation was loaded onto a GSH-column and the protein of interest eluted with 
a buffer containing reduced glutathione. The protein containing fractions were pooled 
and the reduced glutathione was removed using a desalting column (HiPrep Desalting 
26/10). The obtained protein solution was incubated with PreScission protease at 
4 °C overnight. In the next step another GSH-column was performed to separate the 
target protein from the cleaved GST-tag, followed by a S200 (26/60) size exclusion 
chromatography (Figure 3.6–1). Selected fractions were analyzed by SDS-PAGE.  
 
Figure 3.6–1 Size exclusion chromatography of GST-C2B.  
A The blue line displays the UV absorption at 280 nm which is plotted against the elution volume. The 
fraction numbers are shown in red. The elution maximum at 195 ml corresponds to the C2B-dimer.  
B The 15 % coomassie-stained SDS-PAGE gel of GST-C2B contains selected fractions of the purification. 
M indicates the molecular weight marker in kDa, L is the protein sample before loading on the size 
exclusion column. The numbers refer to the fractions of the size exclusion chromatography and the 
target molecule is marked by an arrow. 
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3.7 Purification of GST-C2C 
The C2C-domain was expressed in E. coli Rosetta 2 (DE 3) cells using the 
autoinduction system (see section 2.2.2.1.2). After cell lysis, the protein solution was 
loaded onto a GSH-column and the target protein was eluted using reduced 
glutathione. The pooled elution fractions were incubated with PreScission protease at 
4 °C to cleave off the GST-tag. An SDS-gel confirmed the successful cleavage and the 
protein was concentrated and loaded onto a S200 (16/60) size exclusion column 
(Figure 3.7–1). Afterwards, a second GSH-column was performed to separate the 
GST-tag and the C2-domain. According to their sizes both proteins eluted in the same 
peak from the size exclusion column. Selected fractions were analyzed by SDS-PAGE.  
 
Figure 3.7–1 Size exclusion chromatography of GST-C2C.  
A The UV absorption at 280 nm in the chromatogram is depicted as a blue line which is plotted against 
the elution volume and the fraction numbers are shown in red. There is an elution maximum at 103 ml 
corresponding to the C2C-dimer.  
B The 15 % coomassie-stained SDS-PAGE gel of GST-C2C contains selected fractions of the purification. 
M indicates the molecular weight marker in kDa, S (supernatant) and P (pellet) are samples after cell 
lysis. The numbers 37 and 38 are samples from the GST-column elution peak. F shows the 
flow-through of the second GSH-column and GST the elution peak. The numbers 15 to 26 refer to the 
fractions of the size exclusion chromatography. The arrow marks the target protein. 
3.8 Purification of GST-C2C-phos 
In order to mimic a phosphorylation site identified in an experiment described in 
section 3.15 in the C2C-domain of otoferlin the threonine at position 448 was mutated 
into an aspartic acid using the QuikChange protocol (see section 2.1.3). The protein 
was expressed and purified like the wild type form. After autoinduction expression in 
E. coli Rosetta 2 (DE 3), the harvested cells were lysed and the protein of interest was 
extracted from the protein solution using a GSH-column. The GST-tag was cleaved off 
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during incubation with PreScission protease overnight at 4 °C. The cleaved protein 
was concentrated and a S200 (16/60) size exclusion chromatography (Figure 3.8–1) 
was performed. The C2-domain and the GST-tag eluted in the same peak of the size 
exclusion chromatography due to their size. The remaining GST-tag was removed by 
performing a second GSH-column. Selected fractions were analyzed by SDS-PAGE. 
 
Figure 3.8–1 Size exclusion chromatography of GST-C2C-phos.  
A The blue line displays the UV absorption at 280 nm which is plotted against the elution volume. The 
fraction numbers are shown in red. The elution maximum at 85 ml corresponds to the C2C-phos-dimer.  
B The 15 % coomassie-stained SDS-PAGE gel of GST-C2C-phos contains selected fractions of the 
purification. M indicates the molecular weight marker in kDa, L is the loaded protein sample and the 
numbers refer to the fractions of the size exclusion chromatography. The target protein is marked by 
an arrow. 
3.9 Purification of GST-C2E 
The C2E-domain of otoferlin was cloned into the pGEX-6P-3 vector containing a 
GST-tag and expressed using the autoinduction system. After cell lysis, the protein 
solution was loaded onto a GSH-column. The protein of interest was eluted using 
reduced glutathione. The GST-tag was cleaved off overnight at 4 °C by adding 
PreScission protease. In the following step a S200 (16/60) size exclusion 
chromatography (Figure 3.9–1) was performed. Due to their size the GST-tag and the 
C2-domain eluted in the same fractions. To separate the two proteins a second 
GSH-column was performed. Selected fractions were analyzed by SDS-PAGE.  
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Figure 3.9–1 Size exclusion chromatography of GST-C2E.  
A The blue line displays the UV absorption at 280 nm which is plotted against the elution volume. The 
fraction numbers are shown in red. The elution maximum at 80 ml corresponds to the C2E-dimer.  
B The 15 % coomassie-stained SDS-PAGE gel of GST-C2E contains selected samples of the purification. 
M indicates the molecular weight marker in kDa, L is the protein sample loaded on the size exclusion 
column and the numbers refer to the collected fractions. 
3.10 Purification of C2F-fragments 
All C2F-fragments shown in this work were expressed and purified following the 
same protocol. The proteins were cloned into the pGEX-6P-3 vector and 
overexpressed in E. coli Rosetta 2 (DE 3) cells using the autoinduction system. The 
supernatant resulting from cell lysis was loaded onto a GSH-affinity column. After 
elution of the target protein with a buffer containing reduced glutathione, the GST-tag 
was cleaved off overnight at 4 °C by adding PreScission protease. After cleavage the 
protein was loaded on a superdex S200 (16/60) size exclusion column. The GST-tag 
and the target protein eluted in the same elution peak due to their similar size and the 
ability to form dimers. A second GSH-column was performed to separate both 
proteins. Selected fractions were analyzed by SDS-PAGE. Before thermophoresis 
measurements, the proteins were incubated with Chelex for 1 h at 4 °C to remove all 
Ca2+-ions.  
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3.10.1 GST-C2F wild type  
 
Figure 3.10–1 Size exclusion chromatography of GST-C2F.  
A The UV absorption at 280 nm in the chromatogram is depicted as a blue line which is plotted against 
the elution volume and the fraction numbers are shown in red. There is an elution maximum at 80 ml 
corresponding to the C2F-dimer.  
B The 15 % coomassie-stained SDS-PAGE of GST-C2F contains selected samples of the purification. M 
indicates the molecular weight marker in kDa and L is the loaded protein sample. The numbers 18 to 
21 refer to the fractions of the size exclusion chromatography. Numbers 7 to 10 represents the protein 




Figure 3.10–2 Size exclusion chromatography of GST-C2F-phos.  
A The blue line displays the UV absorption at 280 nm which is plotted against the elution volume. The 
fraction numbers are shown in red. The elution maximum at 85 ml corresponds to the C2F-phos-dimer.  
B The 15 % coomassie-stained SDS-PAGE gel of C2F-phos contains selected samples of the purification. 
The samples 19 to 24 indicate the fractions of the size exclusion chromatography. M is the molecular 
weight marker in kDa, the numbers refer to the fractions of the size exclusion. F is the flow through of 
the second GSH-column containing the protein of interest and GST is the elution peak of the second 
GSH-column containing the GST-tag and not cleaved protein. The target protein is marked by an arrow. 
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The C2F-phos-fragment contains three mutations (S1777D, S1808D and T1860D). 
These positions were found to be phosphorylated by the CaMKIIδ during a 
phosphorylation assay (see section 3.15). In order to simulate these phosphorylation 
sites a synthetic gene was ordered (GeneArt®, lifetechnologies) in which the three 
amino acids were replaced by aspartate residues.  
3.10.3 C2F aspartate mutants 
In case of synaptotagmin 1 C2A the necessity of five specific aspartate residues for the 
Ca2+-binding process was detected (see section 1.4.1) [36]. The first aspartate residue 
in the otoferlin C2F-domain is embedded in an EDDDF motif. At the position of the 
fifth aspartate the sequence contains two aspartate residues next to each other 
(SADDF). Only one aspartate residue in the sequence is present at the positions two, 
three and four. To check the influence of the predicted aspartate residues in the 
binding region of the C2F-domain of otoferlin four mutants were created in which the 
second to fifth predicted residues were mutated. In case of the aspartate at position 
five the additional aspartates in the direct neighborhood may substitute the mutated 
residue and a coordination of Ca2+ might still be possible. Due to this situation both 
aspartates at position five were mutated to prevent that the other aspartate is 
inheriting this function. By mutating the selected position to an asparagine and 
subsequent thermophoresis measurements, the influence of a specific aspartate 
during the Ca2+-binding process could be analyzed. The expression and purification 
was equal for all three mutants.  
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Figure 3.10–3 Size exclusion chromatography of GST-C2F-D1N.  
A The UV absorption at 280 nm in the chromatogram is depicted as a blue line which is plotted against 
the elution volume and the fraction numbers are shown in red. There is an elution maximum at 180 ml 
corresponding to the C2F-D1N-dimer.  
B The 12.5 % coomassie-stained SDS-PAGE gel of GST-C2F-D1N contains selected samples of the 
purification. M indicates the molecular weight marker in kDa, “bc” is the protein before cleavage of the 
GST-tag and “ac” the sample after the cleavage reaction. The numbers refer to the fractions of the size 
exclusion chromatography. The target protein is marked by an arrow. 
3.10.3.2 GST-C2F-D2,3N 
 
Figure 3.10–4 Size exclusion chromatography of GST-C2F-D2,3N.  
A The blue line displays the UV absorption at 280 nm which is plotted against the elution volume. The 
fraction numbers are shown in red The elution maximum at 85 ml corresponds to the 
C2F-D2,3N-dimer.  
B The 12.5 % coomassie-stained SDS-PAGE gel of GST-C2F-D2,3N contains selected samples of the 
purification. M indicates the molecular weight marker in kDa, “bc” the protein before cleavage of the 
GST-tag and “ac” the sample after the cleavage reaction. The numbers refer to the fractions of the size 
exclusion chromatography. The target protein is marked by an arrow. 
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Figure 3.10–5 Size exclusion chromatography of GST-C2F-D1,2,3N.  
A The UV absorption at 280 nm in the chromatogram is depicted as a blue line which is plotted against 
the elution volume and the fraction numbers are shown in red. There is an elution maximum at 85 ml 
corresponding to the C2F-D1,2,3N-dimer.  
B The 12.5 % coomassie-stained SDS-PAGE of GST-C2F-D1,2,3N contains selected samples of the 
purification. M indicates the molecular weight marker in kDa, “bc” the protein before cleavage of the 
GST-tag and “ac” the sample after the cleavage reaction. The numbers refer to the fractions of the size 
exclusion chromatography and the target protein is marked by an arrow. 
3.10.3.4 GST-C2F-D4N 
 
Figure 3.10–6 Size exclusion chromatography of GST-C2F-D4N.  
A The blue line displays the UV absorption at 280 nm which is plotted against the elution volume. The 
fraction numbers are shown in red. The elution maximum at 83 ml corresponds to the C2F-D4N-dimer.  
B The 12.5 % coomassie-stained SDS-PAGE of GST-C2F-D4N contains selected samples of the 
purification. M indicates the molecular weight marker in kDa, P (pellet), “bc” the protein before 
cleavage of the GST-tag and “ac” the sample after the cleavage reaction. The numbers refer to the 
fractions of the size exclusion chromatography and the target protein is marked by an arrow. 
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The pga mutation affects an aspartate in the C2F-domain of the protein which is 
mutated to a glycine. Mice which are carrying this mutation are deaf [54]. According 
to predictions from Jiménez and Bashir [20] this mutation is located in the loop 
region between β-strands two and three. Due to considerations that ferlin C2-domains 
exist in the type II topology the affected loop is located on the opposite end than the 
Ca2+-binding region. 
 
Figure 3.10–7 Size exclusion chromatography of GST-C2F-pga.  
A The UV absorption at 280 nm in the chromatogram is depicted as a blue line which is plotted against 
the elution volume and the fraction numbers are shown in red. There is an elution maximum at 85 ml 
corresponding to the C2F-pga-dimer.  
B The 12.5 % coomassie-stained SDS-PAGE gel of GST-C2F-pga contains selected samples of the 
purification. M indicates the molecular weight marker in kDa, G is the sample after cell lysis, S 
(supernatant) and P (pellet) are samples after centrifugation and the numbers 32 and 33 are samples 
of the GSH-column elution peak. “Ac” is the sample after cleavage of the GST-tag, the numbers 19 to 22 
refer to the fractions of the size exclusion chromatography and F (flow-through) and GST are samples 
of the second GSH-column. The target protein is marked by an arrow. 
3.10.5 GST-C2F-E1804del 
The E1804del mutation in the C2F-domain was initially found in humans having a 
temperature sensitive deafness if the body core temperature rises as little as 1 °C. If 
the affected people become afebrile the hearing status return to normal [17]. The 
deletion of the glutamic acid in the C2F-fragment was created using the QuikChange 
protocol.  
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Figure 3.10–8 Size exclusion chromatography of GST-C2F-E1804del.  
A The blue line displays the UV absorption at 280 nm which is plotted against the elution volume. The 
fraction numbers are shown in red. The elution maximum at 85 ml corresponds to the 
C2F-E1804del-dimer.  
B The 12.5 % coomassie-stained SDS-PAGE of GST-C2F-E1804del contains selected samples of the 
purification. M indicates the molecular weight marker in kDa, G is the sample after cell lysis, S 
(supernatant) and P (pellet) are samples after centrifugation and the numbers 29 and 33 are samples 
of the GSH-column elution peak. “Ac” is the sample after cleavage of the GST-tag, the numbers 19 to 22 
refer to the fractions of the size exclusion chromatography and F (flow through) and GST are samples 
of the second GSH-column. The target protein is marked by an arrow. 
3.11 Purification of His6-C2DEF 
The otoferlin fragment containing the last three C2-domains was cloned into the 
pET28a vector and expressed in E. coli Rosetta 2 (DE3) by autoinduction 
(see section 2.2.2.1.2) [57]. The protein was purified from inclusion bodies 
(see section 2.2.2.3). The protein containing supernatant was loaded onto a His-Trap 
(Figure 3.11–1) and the protein was eluted using an imidazole gradient. Selected 
fractions were analyzed by SDS-PAGE. 
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Figure 3.11–1 His6-column chromatography of His6-C2DEF.  
A The UV absorption at 280 nm in the chromatogram is depicted as a blue line which is plotted against 
the elution volume and the fraction numbers are shown in red. There is an elution maximum at 145 ml 
corresponding to the His6-C2DEF-fragment.  
B The 7.5 % coomassie-stained SDS-PAGE gel of His6-C2DEF contains selected samples of the 
purification. M indicates the molecular weight marker in kDa and the numbers refer to the fractions of 
the His-Trap chromatogram. The target protein is marked by an arrow. 
3.12 Purification of Dynamin-1-Strep 
 
Figure 3.12–1 Strep-column chromatography of dynamin-1-Strep.  
A The blue line displays the UV absorption at 280 nm which is plotted against the elution volume. The 
fraction numbers are shown in red. The elution maximum at 105 ml corresponds to the 
dynamin-1-Strep-fragment.  
B The 12.5 % coomassie-stained SDS-PAGE of dynamin-1-Strep contains selected samples of the 
purification. M indicates the molecular weight marker in kDa, G is a sample after cell lysis and the 
samples S (supernatant) and P (pellet) are samples after centrifugation. The numbers refer to the 
fraction of the Strep-column and the target protein is marked with an arrow. 
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The dynamin-1 was cloned into the pPSG-IBA5 vector containing a Strep-tag using the 
StarGate cloning kit. The Strep-tagged protein was expressed in E. coli SoluBL21 cells 
and harvested 16 h after induction with IPTG. After cell lysis the obtained 
supernatant was loaded onto a Strep-column (Figure 3.12–1) and the protein of 
interest was eluted using desthiobiotin. Selected fractions were analyzed by 
SDS-PAGE. 
3.13 Crystallization 
Except for dynamin-1 and the otoferlin C2DEF-fragment all purified proteins 
described in section 3.2 to 3.10.5 were tested in several crystal screens (see section 
2.1.6). For these trials different protein concentrations and temperatures were tested 
(see section 6). For the C2B-domain a few very small crystals were obtained which 
unfortunately did not diffract. 
Initial crystallization screenings of the native C2ABC-fragment were done in 96-well 
plates pipetted by the PHENIX IRE pipetting robot (Rigaku). Eleven crystallization 
screens (see section 2.1.6) were tested. At protein concentrations of 4 mg/ml small 
C2ABC crystals were obtained in the condition E8 of the JBScreen Classic (1,2,4,5) 
(0.5 M KCl, 10 % glycerol, 12 % PEG8000). Crystal optimization was done using the 
sitting-drop vapour-diffusion technique (24-well sitting drop crystallization plate). 
Droplets with a volume of 2 µl were obtained by mixing protein and reservoir 
solution in a 1:1 ratio. For optimization different concentrations of glycerol 
(6 %-12 %) and PEG8000 (6 %-12 %) were tested. Well diffracting crystals were 
obtained from a condition containing 0.5 M KCl, 6 % glycerol and 12 % PEG8000. The 
crystals were washed in cryoprotectant solution containing reservoir solution and 
additionally 12.5 % glycerol before flash-cooling in liquid nitrogen. Diffraction images 
were collected at the Bessy Beamline 14.1 (Berlin, Germany) equipped with a 
PILATUS 6M detector. The measured crystal diffracted to a resolution of 1.6 Å. The 
obtained data were indexed, integrated and merged using the XDS package [58,59]. 
The C2ABC-fragment crystallized in space group P21 (estimated based on systematic 
absences) with unit cell constants of a = 74.14 Å, b = 172.20 Å and c = 123.31 Å, 
β = 104.34°. The determined Matthews coefficients of 2.76 Å3/Da (corresponds to 
55.49 % solvent content) or 2.21 Å3/Da (44.36 % solvent content) indicates that four 
or five molecules are present in the asymmetric unit. Molecular replacement trials 
were performed using the known structure of the otoferlin C2A-domain (PDB id: 
3L9B) and other known C2-domains (dysferlin PDB id: 4IQH, synaptotagmin-1 PDB 
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model of the C2A-domain comprised less than 7 % of all protein atoms occupying the 
asymmetric unit. Because of this the results of the translation function search did not 
gave a clear true solution which would be distinguishable from many other false ones 
as all of the solutions have similar Z-scores.  
As an alternative, 500 mM of KCl in the crystallization condition was partly (30 to 
50 %) or completely replaced by KI or KBr in order to obtain derivative crystals with 
incorporated heavier halide atoms which could be used to solve the phase problem 
using SIR/SIRAS or SAD/MAD method.  
The production of seleno-methionine derivatised protein failed because no protein 
was expressed in minimal medium. In addition heavy metal soaks (HgCl2, K2PtCl4) 
were done to obtain derivative crystals.  
 
 
Figure 3.13–1 Crystals of the otoferlin C2ABC-fragment.  
A First C2ABC-fragment containing crystals were obtained in a condition containing 0.5 M KCl, 10 % 
glycerol and 12 % PEG8000.  
B Through optimization of the crystallization condition with 0.5 M KCl, 6 % glycerol and 12 % 
PEG8000 bigger and nice diffracting crystals were gained. 
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3.14 Pull-down assay to identify possible interaction partners 
To get information about possible interaction partners of otoferlin, pull-down assays 
were performed and the products analyzed by mass spectrometry. The spectrometry 
measurements and data analysis were done by Sunit Mandad in the lab of Prof. 
Henning Urlaub.  
In the first experiment, His6-tagged C2ABC was bound to Ni2+-beads and incubated 
with lysed mouse brain. The pull-down samples were loaded onto a gradient-SDS gel, 
digested with trypsin and analyzed by mass spectrometry.  
Amongst others dynamin-1, dynamin-3, dynamin-like 120 kDa protein (OPA1) and 
the dynamin-1-like protein were identified as potential interaction partners. The 
identified dynamins are interesting potential interaction partners because of their 
known function in endocytosis [60–62]. 
Due to possible unspecific binding of proteins to the used Ni2+-beads a second shorter 
C2ABC-fragment containing a Strep-tag was tested. As before, the C2ABC was bound to 
the Strep-beads and incubated with lysed mouse brain. Again the digestion and mass 
analysis was performed by Sunit Mandad. The Strep-based pull-down revealed again 
dynamin-1 and the dynamin-like 120 kDa protein (OPA1) as potential interaction 
partners.  
 
Due to the results that dynamin was found in both performed pull-down assays it was 
cloned into a vector containing a Strep-tag. The last part of the protein was not 
included for cloning because proline-rich regions are known to be unstructured and 
very difficult to crystallize [63].  
In the next step, the His6-tagged C2ABC and the Strep-dynamin 1 were tested for 
interaction. Each protein was bound to its tag-specific beads and incubated with the 
other one.  
The Ni-beads with the bound C2ABC were incubated with the Strep-tagged 
dynamin 1-fragment. The sample analysis with SDS-PAGE showed a dynamin band in 
the negative control of Ni-beads with dynamin 1. Usually no protein should be bound 
but it seems that dynamin 1 is able to bind unspecific to Ni-beads. In the second 
experiment dynamin 1 bound to Strep-beads was incubated with the His6-tagged 
C2ABC. This time, no unspecific binding to the beads was detected and the Strep 
pull-down was performed again. Lane 2 on the following gel (Figure 3.14–1) contains 
the pull-down sample after incubation of both proteins showing only one band. In 
comparison to lane 1 in which only dynamin on Strep-beads was loaded, the band in 
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lane 2 shows only dynamin 1. This suggests that that no interaction takes place 
between the two tested proteins. In comparison in lane 6 both proteins were added.  
 
 
Figure 3.14–1 Pull-down assay with dynamin 1 and otoferlin-C2ABC. M indicates the molecular weight 
marker in kDa. Lane 1 contains dynamin 1 bound to Strep-beads, lane 2 is the pull-down sample where 
C2ABC was added to the bound dynamin 1, no bands of otoferlin C2ABC were found. Lane 4 and 5 
contain samples of dynamin 1 and C2ABC alone. In lane 6 both proteins were mixed. 
3.14.1 Pull-down assay using Eupergit beads 
To analyze if the previous pull-down results were detergent dependent, five different 
detergents were tested for lysing brain synaptosomes in the next experiment. 
Additionally, another type of beads was used. The amino and thiol groups of the 
proteins can react with the oxirane groups of these Eupergit beads by nucleophilic 
attack and form very stable C-N and C-S bonds [64]. Remaining binding sites on the 
beads were blocked through incubation with glycine.  
In the first step, the His6- and Strep-tagged versions of C2ABC were bound to the 
Eupergit beads, followed by the incubation with possible interaction partners. In this 
experiment synaptosomes (prepared by Sunit Mandad) from mouse brain were 
mixed with different detergents and added to the Eupergit bound proteins and 
incubated overnight. For the negative control Eupergit beads treated with glycine 
were also mixed with synaptosomes. After several washing steps, the samples were 
digested with trypsin and analyzed by mass spectrometry by Sunit Mandad. The 
control gel (Figure 3.14–2) showed that the pull-down was successful. B marks the 
samples containing the beads with bound C2ABC after incubation with the mouse 
synaptosomes. Well defined bands of the two different C2ABC-fragments were 
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Figure 3.14–2 Gradient control gel of the Eupergit pull-down. The control lane contains the glycine 
treated Eupergit beads incubated with lysed synaptosomes. S indicates the removed supernatant of 
synaptosomes after incubation. B indicates the final sample of beads treated with protein and 
incubated with lysed synaptosomes. 
 
The Table 3.14-1, Table 3.14-2 and Table 3.14-3 show proteins which were identified 
as candidates for interaction partners of otoferlin. All considered proteins were found 
at least in three independent samples of all performed pull-down experiments (Table 
3.14-1). In case of dynamin, AP2 and the 14-3-3 protein different isoforms or 
subunits were detected. All seven isoforms of the 14-3-3 protein were identified by 
mass spectrometry due to their high sequence similarity [65], and all are considered 
to interact with otoferlin. The AP2 adaptor complex consists of five subunits [66]; in 
our pull-down experiments we identified four of them, only the subunit σ is missing. 
Dynamin was found in all three existing forms [67,68]. In one experiment only 
fragments of dynamin were identified which are identical in all three forms. To get 
further information about the possible interaction partners of otoferlin proximity 
ligation assay, co-immunoprecipitaion assays or yeast-to-hybrid experiments could 
provide insight. The third table (Table 3.14-3) contains proteins which play a role in 
cellular respiration; due to this fact they are likely no specific interaction partners for 
otoferlin. Table 3.14-2 shows proteins which probably are not potential interaction 
partners of otoferlin based on their function or location. Therefore, a further analysis 
of the proteins in Table 3.14-3 and Table 3.14-2 is not planned.  
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Table 3.14-1 Identified proteins from three different detergent samples analyzed by mass 
spectrometry. In this table proteins are listed which were found at least three times. Additionally their 
known function and location distinguish these proteins as reasonable interaction partners of otoferlin. 
For some proteins different isoforms were identified. 
Identified proteins  UniProt entry 
AP2 complex  Subunit α-1 P17426 
 Subunit α-2 P17427 
 Subunit β Q9DBG2-2 
 Subunit µ P84091 
Dynamin Dynamin-1 P39053 
 Dynamin-2 P39054 
 Dynamin-3 Q8BZ98 
14-3-3 protein Isoform α/β Q9CQV8 
 Isoform γ P61982 
 Isoform ζ/δ P63101 
 Isoform η P68510 
 Isoform θ F6VW30 
 Isoform σ O70456 
 Isoform ε P62259 
Endophilin-A1  A2ALV3 
Ras-related protein Rab-3A  P63011 
Ras-related protein Rab-7a  P51150 
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Table 3.14-2 Identified proteins from three different detergent samples analyzed by mass 
spectrometry. Due to their function and cellular localization, the proteins in this table are currently 
beyond the research focus of the involved groups.  
Identified proteins UniProt entry 
Peptidyl-prolyl cis-trans isomerase A P17742 
Tubulin beta-5 chain P99024 
Septin-5 Q9Z2Q6 
Microtubule-associated protein 1A A2ARP8 
Carbonic anhydrase P00920 
Aspartate aminotransferase P05201 
Histone H2B type 1-P Q8CGP2-2 
Glutathione S-transferase P P19157 
Stathmin P54227 
Far upstream element-binding protein 2 Q3U0V1 
Cytoplasmic FMR1-interacting protein 2 Q5SQX6 
Intercellular adhesion molecule 5 Q60625 
Heat shock 70 Q3U2G2 




Protein Slc8a2 Q8K596 
Dihydropyrimidinase-related protein 1 Q6P1J1 
Microtubule-associated protein 2 P20357 
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Table 3.14-3 Identified proteins from three different detergent samples analyzed by mass 
spectrometry. The table contains proteins which are involved in the cellular respiration process.  
Identified proteins UniProt entry 
L-lactate dehydrogenase G5E8N5 
Hexokinase-1 P17710 
Triosephosphate isomerase P17751 
2-oxoglutarate dehydrogenase Q60597-3 
Succinate dehydrogenase iron-sulfur subunit, 
mitochondrial 
Q9CQA3 
Cytochrome b-c1 complex subunit 1, mitochondrial Q9CZ13 
Phosphoglycerate mutase 1 Q9D6J6 
NADH dehydrogenase 1 alpha subcomplex subunit 8 Q9DCJ5 
 
In summary several proteins were identified as potential interaction partners of 
otoferlin. Some endocytotic proteins were found which are reasonable candidates for 
an interaction with otoferlin. In case of dynamin-1 and OPA1 Alexandra Müller of the 
lab of Ellen Reisinger is performing proximity ligation assays (see section 4.3).  
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3.15 Phosphorylation with CaMKIIδ 
Former studies of Meike Herget (Stanford University/School of Medicine) showed 
that the Ca2+/calmodulin dependent serine/threonine kinase II delta (CaMKIIδ) is a 
likely interaction partner of otoferlin in chicken utricles [69]. Further experiments 
from Meike Herget confirmed the interaction of heterologously expressed otoferlin 
and CaMKIIδ in HEK cells and revealed a < 40 nm distance of CaMKIIδ and otoferlin in 
rat inner hair cells. In vitro binding studies showed that the combined C2ABC and 
C2DEF have a higher affinity to bind the kinase than the individual fragments. 
To test if the interaction of CaMKIIδ with otoferlin also results in phosphorylation of 
the protein, an in vitro phosphorylation assay was performed. Due to the absence of a 
posttranslational modification machinery in E. coli, expressed proteins are not 
phosphorylated [70]. Therefore, E coli expressed C2ABC- and C2DEF-fragments of the 
protein were mixed (21 pmol each) and added to a reaction buffer containing 
Ca2+-chloride and calmodulin followed by an incubation step with CaMKIIδ 
(life technologies) for 5 min or 60 min at 30 °C. The samples were loaded onto an 
SDS-PAGE gel and analyzed by mass spectrometry.  
 
 
Figure 3.15–1 Phosphorylation control gel of otoferlin for mass analysis. M indicates the molecular 
weight marker in kDa. The lane below the gel displays in which ratio the kinase was used and at which 
time points the reaction was quenched.  
 
Three independent experiments were performed and only phosphorylation sites 
found in all cases were considered. Both otoferlin fragments were found to be 
phosphorylated by CaMKIIδ. For the negative control, the experiment was performed 
without adding the kinase. In total, ten phosphorylation sites were found. Five of the 
found phosphorylation sites are located within C2-domains (Table 3.15-1)[20]. One 
M 
CaMKIIδ -  - 1:1 1:1 1:10 1:10 
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phosphorylation site is located downstream of the C2C, two in the putative 
C2de-domain and two in the linker region between the domains C2de and C2E.  
 
Table 3.15-1 Sites in otoferlin phosphorylated by CaMKIIδ. The phosphorylation sites are numbered 
form P1 to P10, the position indicates the phosphorylated amino acid position in the protein and the 
location describes in which structural areas these amino acids are located. Phosphorylation sites found 
within C2-domains are underlined. 
phosphorylation site position  location 
P1 T448 C2C domain 
P2 T561 Downstream C2C 
P3 S985 C2D domain 
P4 S1184 Putative C2de domain 
P5 T1197 Putative C2de domain 
P6 S1308 Linker region between C2de and C2E 
P7 S1344 Linker region between C2de and C2E 
P8 S1777 C2F domain 
P9 S1808 C2F domain 
P10 T1860 C2F domain 
 
3.16 Thermal shift assay 
To obtain information about the thermal stability of the available C2-domains of 
otoferlin thermal shift assays were performed. Using the thermal shift assay it is 
possible to distinguish between a folded and an unfolded state of the protein. If the 
protein is proper folded no fluorescence signal of the added dye is detectable because 
no hydrophobic patches are available. With increasing temperatures the protein 
starts to melt. This leads to the exposure of the hydrophobic areas of a protein where 
the fluorescent dye can bind and change the fluorescence signal [71]. Selected 
domains in the absence and presence of Ca2+ were tested to analyze the ability of Ca2+ 
to stabilize the protein. To test the stability of C2-domains in presence of other 
domains different combinations were measured. For each tested C2-domain 100 pmol 
were used and in all cases Ca2+ was added in a final concentration of 200 µM. For the 
samples containing two otoferlin fragments 1:1 ratios were used. SYPRO® Orange 
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was used as a hydrophobic fluorophore. All tested protein combinations were 
measured in sets at least six independent trials.  
In the first experiment the C2ABC-fragment was measured alone and in combination 
with other single C2-domains (Figure 3.16–1). In an additional experiment Ca2+ was 
added to the protein mixture. In case of C2ABC alone in presence and absence of Ca2+ 
the obtained curves look comparable. No differences were obtained in the melting 
temperatures in absence or presence of Ca2+. To analyze the significance of the 
obtained melting temperatures a t-test was performed. This compares the measured 
values of two separate protein samples. The combination of C2ABC and C2B results in 
an increase of approximately 1 °C (p = 0.004). All other tested combinations result in 
similar values than the C2ABC except the combination with C2E and Ca2+. For that 
combination a slight increase in melting temperature was obtained which shows the 
tendency not to be significant. In case of the single C2-domains only the C2D is 
missing. Unfortunately no attempt to express or purify this domain was successful.  
 
Table 3.16-1 Melting temperatures of C2ABC in combination with other C2-domains. Continuous lines 
show samples measured in absence of Ca2+ whereas the dotted lines show samples with Ca2+. In the 
right column of the table the mean values for the melting temperatures and standard deviations are 




Figure 3.16–1 Melting curves of C2ABC in combination with other C2-domains obtained performing 
thermal shift assays. On the y-axis the fluorescence signal is shown and the temperature is displayed 
on the x-axis. Only C2E and C2F show distinct temperature changes in the presence of Ca2+. 
 
The same experiments as for the C2ABC-fragment were done with a protein fragment 
containing only the first two domains of otoferlin (Figure 3.16–2). The obtained 
 C2-domains Tm (°C) 
 C2ABC 45.72±0.23 
 C2ABC+Ca2+ 45.62±0.13 
 C2ABC+C2B 46.40±0.39 
 C2ABC+C2B+Ca2+ 46.71±0.36 
 C2ABC+C2C  45.74±0.27 
 C2ABC+C2C+Ca2+ 45.82±0.40 
 C2ABC+C2E 45.56±0.30 
 C2ABC+C2E+Ca2+ 46.08±0.40 
 C2ABC+C2F  44.70±0.26 
 C2ABC+C2F+Ca2+ 45.88±0.50 
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melting temperatures of C2AB alone and in presence of Ca2+ differ in about 0.8 °C 
(p = 0.018). The combination of C2AB with C2B or C2C both in absence and presence of 
Ca2+ led to an increase in the melting temperature of approximately 2 to 3 °C were 
observed (p = 0.00038 for C2ABC vs C2AB+C2B and p = 0.00011 for C2ABC vs 
C2AB+C2C). This leads to the assumption that either one or both domains form a 
stable complex with the C2AB-fragment. The measurement of C2AB together with C2E 
again showed a higher melting temperature in the presence of Ca2+ which however 
was not significant in comparison to the measurement without Ca2+. The increase in 
presence of Ca2+ indicates that Ca2+ stabilized the protein which could be due to 
binding to the presumed Ca2+-binding site formed by the top loops of the C2E-domain 
(see Figure 1.4–2). 
 
Table 3.16-2 Melting temperatures of C2AB in combination with other C2-domains. Continuous lines 
show samples measured in absence of Ca2+ whereas the dotted lines show samples with Ca2+. In the 
right column of the table the mean values and standard deviation are given. 
 
Figure 3.16–2 Melting curves of C2AB in combination with other C2-domains obtained performing 
thermal shift assays. On the y-axis the fluorescence signal is shown and the temperature is displayed 
on the x-axis. All tested fragments show fluorescence changes in presence of Ca2+ except for the single 
C2AB sample all combinations show a higher melting temperature in the presence of Ca2+.  
 
Next, the C2DEF as well was analyzed by thermal shift assays. It was not possible to 
get evaluable data for the experiment with Ca2+ therefore only one curve is displayed 
in Figure 3.16–3. The measured melting temperature is 2 °C below the melting 
temperature of C2ABC. The combination of both fragments resulted in a temperature 
which is in between the obtained values for each fragment alone. The addition of Ca2+ 
to the mixed fragments increased the temperature of approximately 1 °C. This 
suggests that the fragments are not more stable in presence of Ca2+.  
 C2-domains Tm (°C) 
 C2AB 46.37±0.49 
 C2AB+Ca2+ 45.60±0.34 
 C2AB+C2B 49.71±1.05 
 C2AB+C2B+Ca2+ 50.28±0.41 
 C2AB+C2C  48.10±0.31 
 C2AB+C2C+Ca2+ 49.95±1.97 
 C2AB+C2E 45.71±0.86 
 C2AB+C2E+Ca2+ 46.71±1.03 
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The comparison of the melting temperatures of the combined C2ABC- and 
C2DEF-fragment in absence and presence of Ca2+ showed that both temperatures are 
significantly different (p = 0.0013). 
 
Table 3.16-3 Melting temperatures of C2ABC and C2DEF. Continuous lines show samples measured in 
absence of Ca2+ whereas the dotted lines show samples with Ca2+. In the right column of the table the 
mean values and standard deviation are given. 
 
Figure 3.16–3 Melting curves of C2ABC and C2DEF obtained performing thermal shift assays. On the 
y-axis the fluorescence signal is shown and the temperature is displayed on the x-axis. No higher 
melting temperature was detected if both otoferlin fragments were combined. 
 
In the combination with C2ABC and C2AB the C2-domains B and C showed an increase 
in the melting temperature (Figure 3.16–1, Figure 3.16–2). Therefore both 
C2-domains were analyzed alone, in combination and as well in the presence and 
absence of Ca2+ (Figure 3.16–4). The melting temperatures of the single domains 
without Ca2+ differ in 1 °C whereby C2B shows the higher value. In case of the 
combined domains the temperature is 1.5 °C higher than the single C2B (p = 0.0040 
for C2B vs. C2B+C2C and p = 3.38 x 10-8 for C2C vs. C2B+C2C). Adding Ca2+ to the single 
or combined domains result only in a small change of the melting temperature.  
  
 C2-domains Tm (°C) 
 C2ABC 45.72±0.23 
 C2ABC+Ca2+ 45.62±0.13 
 C2DEF 43.57±0.29 
 C2ABC+C2DEF 44.40±0.27 
 C2ABC+C2DEF+Ca2+  45.35±0.46 
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Table 3.16-4 Melting temperatures of C2B and C2C. Continuous lines show samples measured in 
absence of Ca2+ whereas the dotted lines show samples with Ca2+. In the right column of the table the 
mean values and standard deviation are given. 
 
Figure 3.16–4 Melting curves of C2B and C2C obtained performing thermal shift assays. On the y-axis 
the fluorescence signal is shown and the temperature is displayed on the x-axis. The combination of 
the C2B- and C2C-domains resulted in a higher thermal stability than for the individual domains. 
 
Table 3.16-5 Melting temperatures of C2ABC and C2ABC-I515T. The color code refers to the curve in 
the neighboring graph. Continuous lines show samples measured in absence of Ca2+ whereas the 
dotted lines show samples with Ca2+. In the right column of the table the mean values and standard 
deviation are given. 
 
 
Figure 3.16–5 Melting curves of C2ABC and I515T obtained performing thermal shift assays. On the 
y-axis the fluorescence signal is shown and the temperature is displayed on the x-axis. The 
C2ABC-I515T-mutant shows a different melting temperature in absence and presence of Ca2+ 
compared to the wild type fragment. 
 C2-domains Tm (°C) 
 C2B 46.96±1.15 
 C2B+Ca2+ 47.10±0.73 
 C2B+C2C 48.45±0.45 
 C2B+C2C+Ca2+ 47.95±0.76 
 C2C  45.96±0.47 
 C2C+Ca2+ 46.23±0.15 
 C2-domains Tm (°C) 
 I515T 44.40±0.19 
 I515T+Ca2+ 44.44±0.09 
 C2ABC 45.72±0.23 
 C2ABC+Ca2+ 45.62±0.13 
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The melting temperature of the temperature sensitive mutant I515T which was 
inserted into the C2ABC-fragment was as well analyzed by thermal shift assays 
(Figure 3.16–5). In comparison to the wild type C2ABC the mutant showed a decrease 
in the melting temperature (p = 3.57 x 10-8). This was observed in the absence and 
presence of Ca2+. Due to the similarity of both values the presence of Ca2+ seems not 
to have an influence on the stability of the I515T-mutant.  
 
The performed assay showed that some C2-domains are more stable at higher 
temperatures than others. The addition of Ca2+ to the sample increases the melting 
temperature in some cases. For others no change could be detected in the absence or 
presence of Ca2+. Furthermore, the combination of some selected 
C2-domain-fragments results in a higher thermal stability. The temperature sensitive 
C2ABC-I515T-mutant showed an expected lower melting temperature than the wild 
type fragment.  
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3.17 Ca2+-binding of otoferlin C2-domains 
MicroScale Thermophoresis (MST) was used to determine Kd values for Ca2+-binding 
of different C2-domains (see section 2.2.2.12). This method detects changes in the 
hydration shell, charge or size of the molecules. Using an infrared-laser a precise 
microscopic temperature gradient is generated in the glass capillaries which are filled 
with the sample of choice. The intrinsic tryptophan fluorescence of the protein is used 
to monitor its motion along the temperature gradient. Binding events change the 
hydration shell of the molecule which affects the thermophoretic movements.  
All measured proteins were incubated with Chelex for 1 h at 4 °C to remove all 
bivalent cations. The size exclusion buffer (10 mM HEPES pH 7.4, 150 mM NaCl, 
0.1 % Tween) was used for each tested C2-domain. All measurements took place at a 
constant temperature of 22 °C at the Monolith NT.LabelFree instrument. 
For all measurements the temperature jump (T-jump) data were analyzed. The 
T-jump is sensitive for changes in close proximity to the detected tryptophan. These 
changes can either indicate a direct binding event but can also be caused by a 
conformational change. 
Each experiment was repeated three times with individual samples and the mean 
average was determined. The data were fitted in OriginPro 8.5G using the Hill 
equation (f(c) = unbound+(bound-unbound)/(1+(EC50/c)^n). 
3.17.1 His6-C2AB 
 
Figure 3.17–1 MST measurement of His6-C2AB. On the y-axis the changes in normalized fluorescence 
are shown. The x-axis displays the ligand concentration in µM. Ca2+-concentrations in the range of 
0.6 µM to 20 mM were tested at a final protein concentration of 1 µM. The tested C2AB-fragment 
showed no indication of Ca2+-binding. 
 
The His-tagged C2AB-fragment was measured at a final protein concentration of 1 µM. 
Ca2+ was tested in concentrations of 0.6 µM to 20 mM (Figure 3.17–1). Neither the 
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data derived from the thermophoresis nor the T-jump indicated any binding event 
which would result in a dose-dependent change of the thermophoresis rate.  
3.17.2 C2B 
The C2B-fragment of otoferlin was measured at a final protein concentration of 1 µM. 
Ca2+-concentrations of 0.6 µM to 20 mM were added. During the measurement no 
dose-dependent change in thermophoresis could be detected which would indicate a 
binding event between Ca2+ and the otoferlin C2B-domain (Figure 3.17–2).  
 
Figure 3.17–2 MST measurement of C2B. On the y-axis the changes in normalized fluorescence are 
shown. The x-axis displays the ligand concentration in µM. Ca2+-concentrations in the range 0.6 µM to 
20 mM were tested at a final protein concentration of 1 µM. No binding to Ca2+ could be detected for 
the C2B-domain. 
3.17.3 C2C 
3.17.3.1 C2C-wild type 
The C2C-wild type domain of otoferlin was measured at a concentration of 4 µM, the 
highest Ca2+-concentration added was 200 mM. Only a slight increase in the signal 
was detected. In comparison with the negative measurements with 500 mM EDTA 
there is no significant difference between the two measurements (Figure 3.17–3). 
Because of the similarity of both curves it seems that the C2C-wild type is not able to 
bind any Ca2+-ions.  
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Figure 3.17–3 MST measurement of C2C-wild type. On the y-axis the changes in normalized 
fluorescence are shown. The x-axis displays the ligand concentration in µM. Protein concentrations of 
4 µM and Ca2+-concentrations of 6.1 µM to 200 mM were used. The wild type protein is shown in green 
and the negative control with EDTA in black. Due to the similarity to the negative control it can be 
assumed that the C2C-wild type domain is not able to bind Ca2+. 
3.17.3.2 C2C-phos 
The C2C-phos contains an additional aspartate residue in the top loops of the domain. 
This aspartate was inserted to mimic the found phosphorylation site at this position 
(see section 3.15). A final protein concentration of 1 µM was used and 
Ca2+-concentrations ranging between 6.1 µM and 200 mM. For this modified domain a 
binding curve was obtained and resulted in a Kd of 9.1 ± 0.6 mM. The negative control 




Figure 3.17–4 MST measurement of C2C-phos. On the y-axis the changes in normalized fluorescence 
are shown. The x-axis displays the ligand concentration in µM. The protein concentration was set to 
1 µM and 6.1 µM to 200 mM Ca2+ was added.  
A The binding curve for the C2C-phos is shown in red and the negative control in black.  
B The comparison of the wild type C2C-domain (green) and the pseudo-phosphorylated domain (red) 
shows that the integration of another aspartate into the binding region of the C2C-domain enables the 
Ca2+-binding. 
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3.17.4 C2ABC-His6 
The protein fragment containing the first three C2-domains of the protein was 
measured at a final protein concentration of 1 µM. Ca2+ was added in concentrations 
of 0.6 µM to 20 mM. The green data points indicate the measurement of C2ABC and 
Ca2+. The negative control with 50 mM EDTA is presented in black indicating no 
binding event (Figure 3.17–5). Both measurements show a minor fluorescence 
change. However, based on the similarity to the negative control the C2ABC-fragment 
did not show any binding to Ca2+.  
 
Figure 3.17–5 MST measurement of C2ABC-His6. On the y-axis the changes in normalized fluorescence 
are shown. The x-axis displays the ligand concentration in µM. C2ABC was measured at a concentration 
of 1 µM and Ca2+ was added in the range of 0.6 µM to 20 mM. The thermophoresis measurement of 
C2ABC and Ca2+ is shown in green and the EDTA negative control in black. No Ca2+-binding event could 
be detected. 
3.17.5 C2F 
During this work several fragments of the C2F-domain were expressed and purified. 
Next to the wild type domain a fragment containing three pseudo-phosphorylation 
sites was generated with aspartate residues replacing phosphorylated serine or 
threonine residues. Additionally four mutants were created in which the important 
aspartates for Ca2+-binding were replaced by asparagine residues to analyze the 
influence of each aspartate within the Ca2+-binding process. With C2F-pga and 
C2F-E1804del two mutants were investigated which are known to result in hearing 
impairment in mice or humans. All these fragments were tested for Ca2+-binding with 
MST (Table 4.2-1).  
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3.17.5.1 C2F wild type 
For the C2F wild type, the protein was measured at 1 µM and the used 
Ca2+-concentrations ranged between 0.6 µM and 20 mM. The obtained binding curve 
was fitted with the Hill Fit and resulted in a Kd value of 449 ± 20.8 µM. As negative 
control 50 mM EDTA was added to the reaction mixture. By adding Mg2+ it was 
possible to obtain a binding curve with much less affinity than with Ca2+. Up to 20 mM 
Mg2+ no saturation could be reached and no Kd value could be obtained (Figure 3.17–
6).  
By increasing the salt concentration in the buffer to 300 mM NaCl it was possible to 
obtain a more distinct plateau for the bound state (Figure 3.17–7). This resulted in a 
different dissociation constant (Kd = 290 +/- 14.4 µM). It is known from literature that 
the addition of phosphatidylinositol 4,5-bisphosphate (PIP2) to the C2F-domain of 
syt-1 decreases the Kd by 10- to 40-fold [53,72]. The addition of 20 µM PIP2 in this 
case did not improve the measurement or the Kd. No saturation state for the Ca2+/PIP2 
binding could be obtained therefore no Kd value could be calculated.  
 
 
Figure 3.17–6 MST measurement of C2F-wild type. On the y-axis the changes in normalized 
fluorescence are shown. The x-axis displays the ligand concentration in µM. The green curve shows the 
binding of C2F-wild type in a concentration of 1 µM and Ca2+-concentrations between 0.6 µM and 
20 mM.  
A The negative control with 50 mM EDTA is shown in black.  
B The comparison of the Mg2+ (grey) and Ca2+ (green) binding curves shows that the C2F-domain has a 
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Figure 3.17–7 MST measurement of C2F-wild type with different salt concentrations and PIP2. On the 
y-axis the changes in normalized fluorescence are shown. The x-axis displays the ligand concentration 
in µM.  
A Different salt concentration in the buffer resulted in slightly different dissociation constants. The 
green curve represents a measurement with a buffer containing 150 mM NaCl (Kd = 449 ± 20.8 µM) 
and the blue one contained 300 mM NaCl (Kd = 290 +/- 14.4 µM).  
B The addition of PIP2 did not result in an improvement of the Kd. No saturation could be obtained 
during MST measurements. 
3.17.5.2 C2F-phos 
The C2F-phos-fragment was measured at a concentration of 1 µM. In contrast to the 
wild type the Ca2+-chloride concentration was increased up to 200 mM to reach an 
evaluable plateau for the bound state. The fitted data resulted in a Kd = 6.3 ± 0.4 mM. 
The negative control was measured in the presence of 500 mM EDTA and also for this 
modified C2-domain a binding affinity to Mg2+ was found. The Mg2+ was added in a 
concentration of 200 mM. The affinity to Ca2+ is much higher than the affinity to Mg2+ 
(Figure 3.17–8).  
In comparison to the wild type domain the C2F-phos shows a lower affinity to bind 
Ca2+. Additional to the normal Ca2+-, Mg2+- and EDTA-measurements an experiment 
with 20 µM PIP2 was done. A decrease in the amplitude of the signal was detected and 
the obtained Kd-value with 5.26 ± 0.36 mM is in the same range as without PIP2 
(Figure 3.17–9).  
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Figure 3.17–8 MST measurement of the C2F-phos. On the y-axis the changes in normalized 
fluorescence are shown. The x-axis displays the ligand concentration in µM.  
A The C2F-phos (red) was measured in a concentration of 1 µM and mixed with Ca2+-concentrations 
ranging from 6.1 µM to 200 mM. The negative control with 500 mM EDTA is shown in black.  




Figure 3.17–9 Comparison of C2F-wild type and C2F-phos MST curves.  
A The wild type binding curve is shown in red. The red curve shows the C2F-domain in which the three 
phosphorylation sites were mutated into aspartate residues. In comparison to the wild type domain 
the pseudo-phosphorylated C2F shows a lower affinity to bind Ca2+. 
B MST measurement of C2F-phos in presence of 20 µM PIP2, no increase of the Kd could be observed.  
 
3.17.5.3 Aspartate mutants of C2F 
 
Selected aspartate residues in synaptotagmin 1 C2A seem to have specific influence of 
the Ca2+-binding ability [36]. The high affinity binding site of the synaptotagmin 1 
C2A-domain is disrupted if the aspartate at position 178 is replaced by an asparagine. 
This position corresponds in the C2F-domain of otoferlin to the position 1760 the 
mutation of which was called D1N. If this would also be the residue responsible for 
the high affinity binding site the Kd of the D1N-mutant would be expected to be much 
A      B 
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higher than the value measured for the wild type. In case of the mutant containing 
three replaced aspartate residues nearly no Ca2+-binding is expected. The 
D2,3N-mutant contains two mutations which should affect the second and the third 
Ca2+-binding site but should not have sufficient influence to affect the high affinity 
site. Next to the fifth aspartate residue predicted to form the Ca2+-binding site is 
another aspartate located. In the D4N-mutant both aspartates were replaced. 
According to the structural situation within the synaptotagmin binding region this 
mutation should mostly affect the Ca2+-binding site three, therefore an influence on 
the high affinity binding site is not expected.  
3.17.5.3.1 C2F-D1N 
 
C2F-D1N was measured in a final protein concentration of 1 µM. Ca2+-concentrations 
were added in the range of 200 mM to 6.1 µM. These high Ca2+-concentrations were 
necessary to obtain the saturation in MST assays. A binding curve could be obtained 
for the D1N-mutant (Figure 3.17–10) whereas the negative control with EDTA did not 
show any increase in the fluorescence. For Ca2+-binding a Kd of 3.7 ± 0.19 mM was 
calculated. The addition of Mg2+-ions instead of Ca2+ also resulted in a binding event. 
Mg2+ showed a much less affinity to the C2F-D1N than Ca2+. The obtained Kd value for 
Mg2+-binding is 10.5 ± 8.06 mM.  
 
 
Figure 3.17–10 MST measurement of C2F-D1N. On the y-axis the changes in normalized fluorescence 
are shown. The x-axis displays the ligand concentration in µM. The D1N-mutant was measured at 1 µM 
and the Ca2+-concentrations range between 6.1 µM and 200 mM.  
A The binding curve of D1N is shown in blue and the negative control with EDTA in black.  
B The comparison between the Ca2+- (blue) and the Mg2+-binding curve (grey) reveals a lower binding 
affinity for Mg2+. 
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3.17.5.3.2 C2F-D2,3N 
The second aspartate mutant was measured under the same conditions as the D1N. 
As before a final protein concentration of 1 µM was used and Ca2+ was added up to 
200 mM. A saturation of the binding curve was reached and results in a Kd value of 
4.6 ± 0.15 mM. The addition of EDTA to the reaction mixture was measured as a 
negative control and showed no indication of any binding event. In a second 
experiment, the binding affinity of Mg2+ was measured. An increase in the 
fluorescence signal was observed but the addition of Mg2+ up to 200 mM was not 
sufficient to reach the saturation. Thus a Kd value for Mg2+ could not be obtained 
(Figure 3.17–11).  
 
 
Figure 3.17–11 MST measurement of C2F-D2,3N. On the y-axis the changes in normalized fluorescence 
are shown. The x-axis displays the ligand concentration in µM. The protein was measured at a 
concentration of 1 µM and Ca2+ was added from 6.1 µM up to 200 mM. 
A Shown in orange is the binding curve of Ca2+ to the C2F-D2,3N aspartate mutant with an obtained Kd 
of 4.6 ± 0.15 mM. The negative control with EDTA is shown in black.  
B For Mg2+-binding (grey) no Kd value could be obtained. 
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Figure 3.17–12 MST measurement of C2F-D1,2,3N. On the y-axis the changes in normalized 
fluorescence are shown. The x-axis displays the ligand concentration in µM. The protein was measured 
at a concentration of 1 µM and Ca2+ was added from 6.1 µM up to 200 mM. 
A The binding curve of Ca2+ is shown in light green together with the EDTA negative control in black.  
B Comparison of the binding curves of Mg2+ in grey and Ca2+ in light green. The used 
Mg2+-concentrations were not sufficient to reach saturation. This shows that the tested domain has a 
higher affinity to bind Ca2+ than Mg2+. 
 
For C2F-D1,2,3N protein concentrations of 1 µM were used and Ca2+ was added in a 
range of 6.1 µM to 200 mM. Saturation was reached and the fitted data results in a Kd 
value of 4.2 ±0.3 mM. The negative control was performed by adding 500 mM EDTA 
to the reaction mixture which showed no binding event during the measurement 
(Figure 3.17–12). The D1,2,3N-mutant also showed an affinity for Mg2+ but the 
highest concentration of 200 mM did not suffice to reach a saturation. From these 
data no KD value could be obtained.  
 
3.17.5.3.4 C2F-D4N 
The protein concentration of the C2F-D4N-mutant was set to 1 µM and 
Ca2+-concentrations between 6.1 µM and 200 mM were added. In the presence of Ca2+ 
a binding curve was obtained which resulted in a Kd of 9.8 ± 0.6 mM. For a negative 
control 500 mM EDTA were added to the sample to confirm that no binding curve is 
obtained in the absence of Ca2+ (Figure 3.17–13). In comparison to Ca2+, Mg2+ was 
tested as well. No Kd value could be calculated because the used Mg2+-concentrations 
did not result in a saturation plateau.  
  
A      B 
3 Results 




Figure 3.17–13 MST measurement of C2F-D4N. On the y-axis the changes in normalized fluorescence 
are shown. The x-axis displays the ligand concentration in µM. The protein was measured at a 
concentration of 1 µM and Ca2+ was added from 6.1 µM up to 200 mM.  
A The Ca2+-binding of the C2F-D4N-mutant is shown in brown and the negative control containing 
EDTA in black.  
B Comparison of the binding curves of Mg2+ in grey and the Ca2+ in brown. Based on the lower affinity 
to Mg2+ no saturation plateau could be reached. 
 
The comparison of the obtained curves for all four mutants shows a similar shape 
(Figure 3.17–14). All created mutants are able to bind Ca2+ under the used conditions. 
The obtained Kd values for C2F-D1N, C2F-D2,3N and C2F-D1,2,3N are very similar. 
They range between 3.7 and 4.6 mM. For the C2F-D4N-fragment the Kd increased to 
9.8 ± 0.6 mM which suggests a lower affinity to bind Ca2+ than for the other three 
tested fragments.  
 
 
Figure 3.17–14 Comparison of the C2F aspartate mutants.  
A All four fragments were measured at a protein concentration of 1 µM and Ca2+-concentrations 
between 6.1 µM and 200 mM. The D1N is shown in blue, D2,3N in orange, D1,2,3N in light green and 
the D4N in brown.  
B Comparison of the aspartate mutants with the C2F wild type curve in green. All tested mutants show 
a lower affinity to bind Ca2+ than the wild type domain. 
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Figure 3.17–15 MST measurement of C2F-pga. On the y-axis the changes in normalized fluorescence 
are shown. The x-axis displays the ligand concentration in µM. For all measurements protein 
concentrations of 1 µM were used, Ca2+ was added in concentrations of 6.1 µM to 200 mM. 
A The binding curve of the pga-mutant is shown in purple and the negative control with 500 mM EDTA 
in black.  
B The Mg2+ affinity shown in grey is lower than the Ca2+-affinity in purple.  
 
The pga-mutant (D1767G) was measured with Ca2+-concentrations of 6.1 µM to 
200 mM and the protein concentration was set to 1 µM. Depicted in purple is the 
thermophoresis measurement of pga which results in a plateau for the bound state. A 
Kd value for Ca2+-binding of 5.1 ± 0.4 mM was obtained. The negative control with 
500 mM EDTA, shown in black, did not indicate any binding events (Figure 3.17–15). 
In comparison to Ca2+ the affinity to bind Mg2+ is much lower. A Kd of 18.9 ± 1.1 mM 
was calculated.  
 
Figure 3.17–16 Comparison of the pga-mutant and the wild type C2F. Both proteins were measured at 
identical concentrations but the Ca2+-concentration for the mutant was increased to the highest 
concentration of 200 mM. The wild type C2F-domain is shown in green and the pga-mutant in purple. 
The curves display a lower Ca2+-binding affinity for the pga-mutant.  
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The comparison of the pga-mutant with the wild type domains shows a weaker 




Figure 3.17–17 MST measurement of C2F-E1804del. On the y-axis the changes in normalized 
fluorescence are shown. The x-axis displays the ligand concentration in µM. Ca2+-concentrations of 
6.1 µM to 200 mM were used at a protein concentration of 1 µM.  
A The pink curve indicates a measurement at 39 °C and the turquoise curve was measured at 22 °C. 
The EDTA negative control is shown in black.  
B In comparison to the colored Ca2+-measurements the measurement of Mg2+ is shown in grey.  
 
For the temperature sensitive mutant C2F-E1804del the measurement was performed 
at two different temperatures (Figure 3.17–17). Shown in pink is the measurement at 
22 °C; this temperature was chosen to compare this mutant with other 
C2-domain-fragments. It was reported in the literature that a 1 °C higher body core 
temperature could cause a temperature dependent hearing impairment [17]. Because 
of this information the second experiment, shown in turquoise, was measured at 
39 °C. In both experiments protein concentrations of 1 µM were used and Ca2+ was 
added in range of 6.1 µM to 200 mM. Each measurement reached a saturation which 
resulted in the following Kd values: 8.4 ± 0.3 mM for the 39 °C measurement and 
10.2 ± 0.3 mM for the room temperature experiment. The negative control was 
performed as before by adding 500 mM EDTA to the reaction mixture. By adding Mg2+ 
to the temperature dependent sensitive mutant no binding could be observed.  
The direct comparison of both curves from the E1804del-mutant with the C2F wild 
type show a seriously decreased affinity for Ca2+-binding (Figure 3.17–18).  
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Figure 3.17–18 Comparison of the C2F wild type and the E1804del-mutant. In contrast to the obtained 
curves for the E1804del-mutant the C2F-wildtype shows a higher affinity to bind Ca2+. The mutant was 
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4 DISCUSSION 
The exact molecular function of the synaptic protein otoferlin has not been elucidated 
so far. It is proposed to play an important role in exocytosis, endocytosis and active 
zone clearance. Currently only the structure of the C2A-domain of otoferlin is 
available. The aim of this thesis was to express and purify several otoferlin fragments 
and further perform analysis regarding the ability to bind Ca2+-ions, binding studies 
to identify potential interaction partners as well as trying to crystallize the otoferlin 
fragments. Additionally the thermal stability of the C2-domains was measured and 
experiments to identify phosphorylation sites and their influence on the Ca2+-binding 
were done. 
4.1 Otoferlin phosphorylation using CaMKIIδ 
Proteins are known to be highly regulated by posttranslational modifications. In this 
work we focused on phosphorylation sites which are known to play an important role 
in regulation of the protein function [73]. Experiments performed by Meike Herget 
(Stanford University/School of Medicine) identified the Ca2+/calmodulin dependent 
serine/threonine kinase II delta (CaMKIIδ) as interaction partner of otoferlin. At the 
inner hair cells Ca2+-ions enter through voltage-dependent Ca2+-channel which are 
opening during acoustic stimulation. The present Ca2+ can activate the CaMKIIδ in the 
next step. Beside this fact further experiments showed that otoferlin and CaMKIIδ are 
in close proximity within the inner hair cells which led to the hypothesis that the 
kinase may phosphorylate otoferlin [69]. This was investigated by incubating two 
otoferlin fragments which contain the C2ABC- and C2DEF-domains of the protein with 
the CaMKIIδ. Ten phosphorylation sites were identified by mass spectrometry in 
three independent experiments. Five of these sites are located within the C2-domains 
whereas the others are part of the linker regions between the C2-domains (Table 
3.15-1). The comparison of the found phosphorylation sites with otoferlin sequences 
of other organisms revealed that P1, P2, P3, P5, P8 and P9 are conserved in all species 
(Figure 4.1–1). The serine at position P4 was found only in human, mouse and rat 
otoferlin, whereas in case of zebra fish and chicken otoferlin an alanine is present at 
this position. At the position of P10 either a threonine or a serine is found, which 
could both be a target for the CaMKIIδ. The phosphorylation sites P6 and P7 seem not 
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to be conserved as they are only present in rat and mouse otoferlin. In the 
C2F-domain two of the three found phosphorylation sites are conserved among 
several ferlin proteins, including dysferlin, myoferlin, FER4 and FER5 [20]. The serine 
at position P8 is highly conserved in afore mentioned proteins whereas P10 is only 
partially conserved. The phosphorylated peptides of P1, P2, P6, P9 and P10 contain 
the CaMKII consensus sequence R/K-X-X-S/T [74]. In case of the five other 
phosphorylation sites the basic amino acid (R/K) at the P-3 positions is missing. 
However, former studies with other CaMKII substrates showed that the mentioned 
consensus motif is not necessary for phosphorylation in all cases [75,76]. 
 
 
Figure 4.1–1 Comparison of the found phosphorylation sites in different organisms. The 
phosphorylation sites are marked in red. The figure was kindly provided by Meike Herget.  
 
Only in very few cases phosphorylation sites were identified within C2-domains, 
namely synaptotagmin 4 (Syt 4) [77], protein kinase C (PKC) [78], cytosolic 
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phopholipase A2 (cPLA2) [79] and rice small C2-domain proteins [80]. These 
phosphorylation sites were shown to influence the binding to phosphatidylserine in 
case of Syt 4 or affect membrane translocation for PKC and cPLA2 [77–80]. In none of 
these studies the influence of phosphorylation sites on the Ca2+-binding was 
investigated. In this study the wild type domains of the otoferlin C2C- and C2F-domain 
were tested for Ca2+-binding by MST and compared with pseudo-phosphorylated 
domains generated by mutating phosphorylated sites into aspartate residues. The 
obtained results showed for the first time that the incorporation of amino acids which 
mimic the phosphorylated state in the two C2-domains of otoferlin affect the 
Ca2+-affinity (see sections 3.17.5.1 and 3.17.5.2).  
It is most likely that other kinases are also able to phosphorylate otoferlin but so far 
no further kinases were tested on this purpose. Additional phosphorylation sites 
might lead to a different behaviour in Ca2+-binding of otoferlin. Moreover, it might be 
possible that different phosphorylation sites within the protein might affect specific 
functions of the protein differently. To make an overall assumption about the general 
influence of phosphorylation sites in C2-domains further kinases and their 
phosphorylation sites have to be tested.  
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4.2 Ca2+-binding of otoferlin C2-domains 
Otoferlin belongs to the family of Ca2+-binding proteins. These proteins participate in 
numerous cellular functions and have the ability to bind Ca2+-ions in specific domains 
[81]. The characteristic parts for Ca2+-binding within otoferlin are its C2-domains. In 
this work most of the purified protein fragments of otoferlin were tested for 
Ca2+-binding using MicroScale Thermophoresis (see section 3.17). 
4.2.1 Ca2+-binding ability of the domains C2A, C2B and C2C 
For the single C2B- and C2C-domain and the three domains containing fragment 
C2ABC-His6 no Ca2+-binding could be detected. Former studies already showed that at 
least the C2A-domain is not able to bind Ca2+ because of the missing aspartate 
residues for ion coordination and a shorter loop 1 in the binding region [15,34,35]. 
Based on alignments of the ferlin C2-domains [15,20] it was shown that in case of the 
C2B-domain also only one aspartate is present in the binding region. Considering 
these finding it is conclusive why it was not possible to obtain a Ca2+-binding curve 
for this domain. Within the C2C-domain a similar situation was found; in the predicted 
Ca2+-binding region only three aspartate residues are present. Also for this domain no 
Ca2+-binding could be detected using MST. A reason could be that in case of the 
otoferlin C2C-domain three aspartate residues are not sufficient to bind one to three 
Ca2+-ions. Another matter could be that the Ca2+-binding within this domain does not 
change the MST signal, which was reported for Syt 1-C2A [82]. In principal, it could be 
possible that three aspartate residues are enough to establish a binding to Ca2+. This 
is the case for the cytosolic phospholipase A2 (cPLA2). Only two aspartate residues 
are present in the top loop 1 and one in top loop 3 (Figure 4.2–1, E). Within the loop 3 
an asparagine residue, which is located at an aspartate position in Syt 1, is involved in 
the Ca2+-coordination. Additionally, an asparagine located in the top loop 2 provides a 
coordination site [83]. The involvement of this asparagine was also shown for the 
phosphoinositide-specific phospholipase C-δ1 (PLC-δ1) (Figure 4.2–1, D) [38]. If we 
take a closer look into the sequence of the second loop in the binding region of 
otoferlin we can find such an asparagine within the C2A- and C2B-domain but not in 
the C2C-domain [20]. Instead two serines are located in the loop 2 of the C2C-domain. 
In case of Syt 1-C2A it was reported that a serine in loop 3 is involved in the 
coordination of Ca2+ [36]. Dependent on the structural arrangement of the otoferlin 
C2C loop 2 one or two serines may provide a coordination site. Based on the results of 
the non-existing C2B and C2C Ca2+-binding obtained from MST measurements in this 
work and in addition with the published data of the C2A-domain [34] it was expected 
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that the C2ABC-fragment is also not able to bind Ca2+ which was confirmed by MST 
measurements. A former study of Johnson et al. showed Ca2+-binding for C2B and C2C 
by measuring the fluorescence spectra as well as performing isothermal titration 
calorimetry [15,53]. According to the predictions of Jiménez and Bashir the 
C2B-domain of otoferlin contains the amino acids 256 to 378 [20]. The C2B-domain 
used by Johnson et al. ends at amino acid 370 which may cause a different structural 
orientation in comparison to the fragment that was used in this work (aa 217 to 414). 
Due to predictions the seven missing amino acids in the Johnson-fragment are part of 
the last β-strand [15,20].  
A comparison of the C2C-fragment (aa 410 to 616) from this work to the 
Johnson-fragment shows that they used different lengths of the linker-region in front 
and behind the C2C-domain [15]. This may result in the different observed 
Ca2+-binding abilities. In the Johnson paper only one Ni-NTA-column is described as a 
purification step which leads to the question if the used protein for Ca2+-binding 
measurements is pure enough to exclude interactions of Ca2+-ions to remaining 
impurities. Altogether our obtained results, the data published in literature and the 
predictions made about the first three C2-domains of otoferlin are most contradictory. 
Solving the structure of these domains would provide information about the actual 
structure of the binding regions and their ability to bind Ca2+-ions.  
 
A performed phosphorylation assay with CaMKIIδ of the C2ABC-fragment of otoferlin 
revealed a phosphorylation site (P1) within the C2C-domain of otoferlin 
(see section 3.15). By mutating the found threonine into an aspartate residue to 
mimic the space and charge of a phosphorylation site and performing MST 
measurements Ca2+-binding could be detected [69]. The phosphorylated threonine is 
located in the top loop 1 next to an asparagine the position of which was predicted to 
be involved in Ca2+-binding [15,20]. The three aspartate residues present in the 
Ca2+-binding region of the C2C-domain probably are not sufficient to bind Ca2+-ions. 
But the insertion of an additional aspartate residue into the top loop 1 seems to 
create a structure which is capable to bind one or more Ca2+-ions. In consideration of 
potentially more existing phosphorylation sites as posttranslational modifications in 
the native protein it is possible that they influence the overall structure and change 
the Ca2+-binding abilities [84,85]. The used Ca2+-concentrations for MST 
measurements range between 6.1 µM and 200 mM and resulted in a Kd value of 
9.1 ± 0.6 mM. Ca2+-concentrations in the inner hair cell are in the order of a few tens 
of µM [86]. Because of this fact the C2C-phos-mutant would not bind Ca2+ under 
physiological conditions.  
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Figure 4.2–1 Ca2+-binding situation in the C2-domain top loop regions of different proteins. Shown in 
yellow are the two or three Ca2+-ions which are coordinated (red dotted line) by different number of 
aspartate residues. Additionally two or three backbone carbonyl groups are involved in the 
Ca2+-coordination.  
A In the Syt 1-C2A-domain five aspartate residues are involved in the binding of three Ca2+-ions.  
B In case of Rab-3A C2A two Ca2+-ions were found in a structure solved by NMR. The Ca2+ at the third 
position marked with a black dotted line was calculated to be present but could not be identified in the 
structure. Four aspartate residues and one asparagine residue (E482) play a role in Ca2+-binding.  
C In the C2-domain of PKCβ five aspartate residues are present and coordinate three Ca2+-ions. The 
E281 belongs to a second C2-molecule in the asymmetric unit of the crystal.  
D The coordination of three Ca2+-ions in the cPCL-δ1-domain involves four aspartate residues and an 
asparagine located on loop 2 of the Ca2+-binding region.  
E In the C2-domain of cPLA2 only three aspartates are present further coordination sites are provided 
by two asparagine residues which are located in loop 1 and loop 2.  
Figure adapted from Perisic et al., 1998; Essen et al., 1996; Sutton and Sprang, 1998; Coudevylle et al., 
2008 and Ubach et al., 1998.  
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4.2.2 Ca2+-binding of the C2F-domain 
Another three phosphorylation sites were found in the C2F-domain of the protein. To 
incorporate amino acids into the wild type domain to mimic the phosphorylation sites 
a synthetic gene was ordered. The affinity of the wild type C2F-domain and the 
pseudo-phosphorylated fragment were tested for Ca2+-binding with MicroScale 
Thermophoresis. The obtained Kd value for Ca2+-binding of the wild type C2F-domain 
was 449 ± 21 µM. Increasing the salt concentration to 300 mM resulted in a much 
lower Kd of 290 ± 14 µM which is similar to already published data about the 
Ca2+-binding of this domain. Ramakrishnan et al. measured the Ca2+-binding ability 
using ITC at a salt concentration of 250 mM and obtained a Kd of 267 µM which is in 
good agreement with the Kd value obtained with MST [35]. Nevertheless, the 
decreased Kd of 290 µM in high salt buffer was still not in the range of physiological 
Ca2+-concentrations in inner hair cells [86]. The Ca2+-binding Kd for 
synaptotagmin 1 C2B was reported in the same order of magnitude (Kd ~200 µM) 
[72,87]. Due to the presence of negatively charged phospholipids the Ca2+-affinity of 
synaptotagmin and protein kinase C is increased [72,88,89]. This leads to the 
assumption that the binding of phospholipids has as well an influence on Ca2+-binding 
in case of otoferlin. Furthermore, additional interaction partners or posttranslational 
modifications [84,85] can play a role in this process. The integration of negatively 
charged aspartate residues at the found phosphorylation sites resulted in an 
approximately 10-fold affinity decrease for Ca2+ (Kd = 6.3 ± 0.4 mM). Two of the three 
pseudo-phosphorylation sites are predicted to be located within the β-strands three 
and seven whereas the third occupies a position in a bottom loop between β-strand 
four and five [20] (Figure 4.2–2). Because of these positions a direct influence like in 
case of the C2C-domain can be excluded. More likely is the assumption that the 
phosphorylation sites within the β-strands cause a change in the structure compared 
to the wild type. Changes in the structure of the core component of the domain 
probably lead to rearrangements of the binding loops as well. In case of 
synaptotagmin it was reported that a single mutation of a coordinating aspartate 
residue can disrupt the highest affinity Ca2+-binding site which leads to a serious 
decrease in Ca2+-affinity for the whole domain. The explanation for this behavior is 
based on the hypothesis that during high affinity Ca2+-binding the surrounding amino 
acids undergo conformational changes in which the binding of a second and third 
Ca2+-ion is facilitated [36]. If a high affinity binding site is also present in the 
C2F-domain of otoferlin it is possible that loop reorganization affects this site which 
would be a possible explanation for the serious decrease in case of the 
pseudo-phosphorylated domain. In this experiment only the phosphorylation of 
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CaMKIIδ was considered despite the presence of many other kinases. It is likely that 
more phosphorylation sites are located within otoferlin as well as other 
posttranslational modifications which also can influence the structure [84,85]. This 
leads to the question if the E. coli expressed C2-domain can be compared to a 
C2-domain in native conditions. 
 
 
Figure 4.2–2 Topology model of the C2F-domain of otoferlin. The eight β-strands are shown in green 
and the loop regions in black. In orange the positions of the phosphorylation sites are indicated.  
 
In this work an aspartate residue was chosen to mimic the phosphorylated serine or 
threonine residues. An alternative could be to incorporate a glutamate residue. It was 
reported that in specific cases one amino acid is a better candidate than the other one 
[90]. Additionally, there are findings that two acidic residues are needed to mimic one 
phosphorylation event [91]. To assure that the obtained results are not dependent on 
the aspartate residue, which was used for replacement, the effect of glutamate should 
be tested in future studies. 
An often reported phospholipid involved in C2-domain binding is 
phosphatidylinositol 4,5-bisphosphate (PIP2). The interaction of PIP2 with 
synaptotagmin 1 increased the affinity to bind Ca2+ [72]. Similar findings were 
reported for the C2F-domain of otoferlin [53]. Two explanations are discussed for this 
behavior. Phospholipids are able to bind at the unsaturated coordination sites of the 
Ca2+-ions or can interact with the cationic patch in the concave face of the β-sandwich, 
called the β-groove [31]. In this work the addition of PIP2 to the C2F wild type domain 
was tested but did not lead to unambiguous results. An increase of the fluorescence 
change was detected but did not reach the saturation plateau, therefore no Kd was 
obtained. It might be possible that the presence of PIP2 causes a higher affinity for a 
second Ca2+-binding event, leading to a further increase in fluorescence change. In 
this case it is obviously not possible to detect the separate events with MST 
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measurements. The same experiment was repeated for the pseudo-phosphorylated 
C2F-domain of otoferlin. The addition of PIP2 during MST measurements resulted in a 
similar Kd as without PIP2. If the Ca2+-binding ability is influenced by the incorporated 
pseudo-phosphorylation sites maybe not enough Ca2+-ions or free coordination sites 
at the ions are available for PIP2 binding. If the PIP2 binding does not occur through 
free coordination sites of Ca2+ but through the β-groove maybe the structural 
rearrangements introduced by the incorporation of the pseudo-phosphorylation sites 
might prevent this binding event. In addition, the negative charge of the 
pseudo-phosphorylation sites might inhibit the binding of the negatively charged 
phospholipids. It is likely that the CaMKIIδ phosphorylation sites are not the only 
posttranslational modifications within this C2-domain.  
4.2.3 Ca2+-binding of C2F-aspartate mutants 
In order to analyze the influence of the five binding aspartate residues within the 
C2F-domain of otoferlin mutants were created in which one, two or three aspartate 
residues were replaced by asparagine (Figure 4.2–3). MicroScale Thermophoresis 
was used to measure the Ca2+-binding. According to the role of the different 
aspartates in Syt 1-C2A [36] it was estimated that in case of the D1N-mutant the 
ability to bind Ca2+ would show a severe decrease. Assuming that the aspartate 
residues in otoferlin-C2F play a similar role as in Syt 1-C2A the high affinity 
Ca2+-binding site would be affected in the D1N-mutant. This would lead to a reduction 
in the Ca2+-binding affinity or maybe to a complete disruption of the binding site. 
Furthermore, the D2,3N-mutant should mostly affect the Ca2 and Ca3 binding sites 
and to minor degree the Ca1 site. The mutation of three aspartates in the 
D1,2,3N-mutant was expected to show a similar observation like the D1N. 
Surprisingly, all measured Kd values were in the same magnitude (~3.7-4.6 mM) 
which suggested that all three mutated aspartates play a comparable important role 
in Ca2+-binding. 
The gained Kd for the D4N-mutant is higher than the three tested mutants before. Due 
to these observations it has to be considered that the highest affinity binding site 
could be located at another position than in Syt 1-C2A. If in case of otoferlin the 
highest affinity binding site would be located at the position of Ca3 of Syt 1-C2A this 
would explain at least the severe changes when D2N, D3N or D4N are involved. 
Unfortunately this hypothesis does not include the D1N. Based on comparisons of the 
Ca2+-binding regions of Syt 1-C2A [36], Rabphilin-3A (Rab-3A) [92], PKC [93], PLA2 
[83] and PLC-δ1 [38] all binding regions show a similar structure and coordination of 
Ca2+-ions. In case of PLA2 and Rab-3A only two Ca2+-ions were identified [83,92] 
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whereas for Rab-3A the binding of a third Ca2+ was predicted [92]. The coordination 
of the Ca2+-ions through aspartate residues, backbone carbonyls and other additional 
amino acids is very similar in all cases. Only slight differences in the coordination can 
be detected in these C2-domains. The shown coordination of Ca2+ to Syt 1-C2A, PKC 
and Rab-3A is almost identical [36,92,93] whereas PLC and PLA2 show minor 
differences (Figure 4.2–1) [38,83]. For PLC and PLA2 one or two aspartates are 
missing and in both domains an 
asparagine residue in the top loop 3 
seems to compensate the missing 
coordination sites [38,83]. Unfortunately 
for PKC, PLA2, PLC-δ1 and Rab-3A no data 
are published in which the high affinity 
binding site was analyzed. Such studies 
could provide insight if the highest 
affinity site is protein specific. 
Summarized it is likely that otoferlin has 
not the same high affinity binding site 
than Syt 1-C2A. To get more information 
about the binding region of otoferlin an 
analysis by NMR, like it was done for 
Syt 1-C2A by Ubach et al., would be 
helpful. 
Figure 4.2–3 Position of the C2F aspartate mutants in the respected structure of Syt 1-C2A. The tested 
otoferlin mutants are shown in violet. 
4.2.4 Ca2+-binding of C2F-mutants with mutations affecting hearing 
Two mutations - known to affect hearing - in the C2F-domain of the protein were also 
analyzed for their ability to bind Ca2+. Mice which carry the pga mutation within the 
C2F-domain of otoferlin are deaf [54]. In a loop region located at the opposite site of 
the Ca2+-binding region an aspartate residue was replaced by a glycine (D1767G) 
[20]. The position of this amino acid indicates that the mutation has no influence on 
Ca2+-binding. Whether or not the exchange of this amino acid in a flexible loop region 
is enough to influence the overall structure of the C2-domain is questionable. Due to 
the position in a flexible bottom loop it is unlikely that this mutation is able to cause 
such a change in the structure that the Ca2+-binding is influenced. The performed 
MicroScale Thermophoresis measurements showed a decrease of Ca2+-affinity for the 
pga-fragment in comparison with the wild type C2F (Figure 3.17–16). With a higher 
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Kd value as the wild type the pga-mutant is not able to bind Ca2+ under physiological 
conditions [86]. Ramakrishnan et al. as well reported a diminished Ca2+-binding for 
C2F-pga [35]. 
 
The E1804del-mutation was found in the human C2F-domain of otoferlin. The 
deletion of glutamic acid at position 1804 leads to temperature sensitive deafness 
[17]. For MicroScale Thermophoresis this mutation was inserted into the C2F-domain. 
Two different temperatures were tested in MST measurements. The first sample was 
measured at 22 °C for comparability with the wild type and other measured 
C2-domains. In this case a binding curve for Ca2+ was obtained. In consideration that 
this deletion leads to temperature sensitive deafness above 38 °C the measurement 
was repeated at 39 °C. As well a Ca2+-binding were detected. The obtained Kd for 39 °C 
(8.4 ± 0.3 mM) is a little bit lower than the value for 22 °C (10.2 ± 0.3 mM). In 
comparison to the wild type curve (Kd = 290 +/- 14 µM) (Figure 3.17–18) both 
E1804del curves display a much lower affinity for Ca2+. Due to the physiological 
Ca2+-concentrations in the order of a few tens of µM [86] the E1804del-mutant is not 
able to bind Ca2+ neither at 22 °C nor 39 °C.  
In both cases it has to be considered that the native protein would likely contain 
different post-translational modifications which can lead to a different folding of the 
domain and consequently to a different behavior. In this case as well interactions 
with phospholipids or other proteins might have an effect as well. 
 
In the following Table 4.2-1 all measured Kd values for the wild type and the different 
mutations of the C2F-domain are listed. It seems that all tested mutations affect the 
C2F-domain in a similar manner. Typically, it would be expected that the aspartate 
mutants have a much higher effect on the Ca2+-binding than the pga-mutant but all 
obtained Kd values are in the same order of magnitude. Except for the wild type 
domain none of the mutants seems able to bind Ca2+ under physiological conditions.  
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Table 4.2-1 Overview of the obtained Kd values of the different C2F-mutants. All measurements took 
place in a sample buffer containing 10 mM HEPES pH 7.4, 150 mM NaCl and 0.1 % Tween at a 
temperature of 22 °C. A final protein concentration of 1 µM was used and the highest used 
Ca2+-concentration was set to 200 mM.  
a The highest Ca2+-concentration was changed to 20 mM.  
b This measurement was performed in the presence of 300 mM NaCl.  
c For the E1804del-mutant a second set of samples at 39 °C were measured. 
 
C2-domain-fragment Dissociation constant (Kd) 
C2F wild type 449 ± 20.8 µMa (290 ± 14.4 µMb) 
C2F-phos 6.3 ± 0.4 mM 
C2F-D1N 3.7 ± 0.2 mM 
C2F-D2,3N 4.6 ± 0.2 mM 
C2F-D1,2,3N 4.2 ±0.3 mM 
C2F-D4N 9.8 ± 0.6 mM 
C2F-pga 5.1 ± 0.4 mM 
C2F-E1804del 10.2 ± 0.3 mM (8.4 ± 0.3 mMc) 
 
It is known that C2-domains bind one to three Ca2+-ions through aspartate 
coordination. In case of Syt 1 the aspartate residues form the binding sites with 
different affinities for Ca2+. Selected mutations showed that it is possible to mutate 
specific aspartates without any influence on the high affinity binding site [36]. Based 
on the possibility to bind more than one Ca2+-ion it might be the case that the 
obtained Kd value of the wild type comprise two binding events which cannot be 
detected separately using MicroScale Thermophoresis. The resulted Kd values of the 
tested aspartate mutants in this work lead to the hypothesis that all aspartates share 
a similar role within the binding process in otoferlin. The mutation of one aspartate 
could affect the whole Ca2+-binding process. It is likely that all present aspartates are 
interconnected to each other and the required conformational change of the involved 
aspartates for Ca2+ coordination is disturbed by a single mutation.  
The influence of at least the two pseudo-phosphorylation sites integrated in the 
β-strands of the C2F-domain probably cause a slightly different folding than for the 
wild type. Therefore it seems likely that the positions of the top loops are changed to 
an arrangement in which no Ca2+-binding under physiological conditions would be 
possible.  
For the pga-mutant another hypothesis was made. According to predictions based on 
homology between C2-domains of closely related proteins the pga-mutation is located 
in the flexible bottom loop of the C2-domain. It is known that mutations which are not 
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part of the active site, interaction areas or binding sites often affect the protein fold or 
decrease the stability of the functional conformation [94]. The incorrect folding can 
lead to degradation or aggregation of the protein. In comparison to the other 
expressed and purified C2F-fragments the pga-mutant showed a much lower 
expression level. This leads to the assumption that the exchanged amino acid is 
relevant for the correct folding of the domain. Furthermore a misfolding of the 
protein is likely to cause a different conformation of the top loops which might not be 
able to bind Ca2+ anymore. Moreover the made predictions could be different to the 
actual structure of the native C2F-domain. Because no structure of the otoferlin 
C2F-domain is known so far the location of the pga-mutation in a structured part of 
the domain cannot be excluded. 
The before mentioned problems during folding can also be caused by in-frame 
deletions like the E1804del which is positioned in a bottom loop of the domain. The 
misfolding resulting from this deletion would explain why no changes in the 
Ca2+-affinity could be detected performing MST measurements at different 
temperatures. The temperature sensitive mutant should show a different behavior at 
temperatures higher than the body temperature in comparison to the tested 22 °C. 
But if the protein was folded incorrectly during expression it is no wonder that we did 
not observe two different affinities at the two tested temperatures.  
In summary all tested mutant C2F-domains seem to be present in conformations 
which are different to the wild type C2F-domain. It is unlikely that the aspartate 
mutants influence the folding of the β-sheet consisting core component of the 
C2-domain. The change in Ca2+-binding probably results from a rearrangement of the 
top loops. The inserted pseudo-phosphorylation sites as well as the 
mutation/deletion known to affect hearing presumably cause a different folding of 
the entire domain. All tested mutations have in common that no Ca2+-binding occurs 
under physiological conditions. 
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4.3 Identification of possible interaction partners of otoferlin 
Based on the so far not clearly affirmed function of otoferlin, interaction partners 
within the inner hair cell could provide an indication for its precise molecular action 
in hearing. To identify these possible interaction partners pull-down experiments 
were performed in which recombinant otoferlin was incubated with lysed 
synaptosomes from mouse brain [56]. Based on the fact that samples from the whole 
mouse brain were used and not specific parts of the inner ear several proteins were 
identified as potential interaction partners which might not be present in the inner 
hair cells. Only proteins which were found at least three times out of nine pull-down 
experiments were considered as potential hits (Table 3.14-1). Figure 4.3–1 shows a 
network of proteins which are related to otoferlin, endocytosis or exocytosis. Beside 
the proteins of Table 3.14-1 clathrin, amphiphysin, synaptojanin, Rab-3A and Rab-3C 
were included. Each of them was found once or twice in our pull-down experiments. 
Furthermore the interactions between some of these proteins were already described 
in the literature. The black lines in Figure 4.3–1 show already published interactions 
and the red dotted lines display the potential interactions that were detected in the 
performed pull-down experiments of this work.  
 
 
Figure 4.3–1 Overview of interaction partners of otoferlin. The green boxes show otoferlin and 
proteins which are potential interaction partners or known to interact with each other from literature 
[66,95–105]. The red dotted lines indicate the proteins which were identified in the pull-down 
experiments of this study. Already known interactions between proteins are displayed by solid black 
lines.  
 
Clathrin, the AP2-complex and dynamin are known to function as core components of 
the clathrin-mediated endocytosis [106]. The AP2 adaptor complex consists of an 
α-adaptin-, a β2-adaptin-, a σ2- and a µ2-subunit [98,107] and belongs to the family of 
heterotetrameric clathrin adaptor complexes. Members of this family are known to 
play a role in different vesicle trafficking pathways within the cells. Each of the four 
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subunits of AP2 has a specific function. Through the α-adaptin subunit the 
AP2-complex is targeted to the plasma membrane. There the assembly of clathrin is 
mediated by the AP2-β2-subunit while the µ2-subunit directly interacts with sorting 
motifs on cargo molecules. For the σ2-subunit no specific role is known so far but it is 
assumed that it plays a role in stabilization of the core domain [66]. The interaction of 
AP2 with otoferlin was published by Duncker et al. [97]. They identified AP2 as 
interaction partner using high-resolution liquid chromatography coupled with mass 
spectrometry. These findings were confirmed by co-immunoprecipitation assays in 
mature hair cells [97]. In this work the α-subunit of AP2 was found in six of nine 
experiments and the µ- and β-subunits were identified four times. Only the σ-subunit 
could not be detected in the performed experiments.  
Moreover, it was published that beside otoferlin, AP2 also interacts with amphiphysin 
[95,96] and dynamin [98]. The hydrophilic and acidic protein amphiphysin was found 
in the brain and contains amongst others an adaptor domain and a SH3-domain [96]. 
Due to the identified interactions of amphiphysin with the α-subunit of AP2 
amphiphysin was suggested to play a role in synaptic vesicle endocytosis. It might 
participate in the recruiting or regulation process of proteins which are involved in 
budding and fission reactions [99]. In our pull-down experiments, amphiphysin was 
identified only once possibly resulting from its role as indirect interaction partner 
through AP2. In this case an indirect interaction with otoferlin can be assumed.  
Like AP2, amphiphysin interacts through its SH3-domain with dynamin [95,96,99]. 
Dynamin itself is a 100 kDa enzyme of the highly conserved GTPase superfamily. It is 
composed of an N-terminal GTPase domain followed by the middle-, PH- and the 
GTPase effector domain and a C-terminal proline-rich domain. [61,63,67,108]. 
Dynamin is involved in scission of clathrin-coated vesicles from the plasma 
membrane [61]. In this process, it is recruited to the necks of the coated pits, 
assembles in form of a spiral on these necks, and mediates the membrane fission 
[106]. Dynamin exists in three isoforms, dynamin-1 and -3 are brain-specific whereas 
dynamin-2 is expressed ubiquitously [61,109]. In our investigations we identified 
dynamin-1 as well as dynamin-3 as potential otoferlin interaction partner. One 
experiment resulted in identified peptides of dynamin which are equal in all three 
isoforms; thus it might be possible that otoferlin can bind to more than one isoform. 
Studies of dynamin-1 and -3 showed that they have overlapping functions in nerve 
terminals. The suggestion that the two proteins also share a set of common binding 
partners was confirmed by western blot analysis [109].  
To test the direct interaction of dynamin-1 with the N-terminal part of otoferlin, 
dynamin-1 was cloned into a Strep-tag containing vector and purified from E. coli. 
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The subcloned dynamin-fragment lacks the C-terminal proline-rich domain. These 
domains are known to be mostly unstructured and very flexible. Furthermore, it is 
very difficult to crystallize proline-rich regions [63,110] and therefore, this domain 
was not included. The direct pull-down of otoferlin and dynamin-1 did not show any 
indications of an interaction between the two tested proteins. It was assumed that the 
binding/interaction of the two proteins would be mediated through the pleckstrin 
homology domain of dynamin [111]. Due to lack of structural information about 
interactions of otoferlin with other proteins, no specific region of otoferlin can be 
proposed to be essential for binding. Studies of Anggono et al. showed that during 
synaptic vesicle endocytosis dynamin-1 is dephosphorylated at serine 774 and 
serine 778. Both phosphorylation sites are located in the proline-rich domain of the 
protein [112,113]. The protein phosphatase calcineurin was reported to 
dephosphorylate these sites, which was suggested to be a key step in dynamin 
activation. The functional role of the dynamin phosphorylation in small vesicle 
endocytosis is still unclear but it is likely that the interaction with the SH3-domain 
containing proteins is regulated by the phosphorylation sites [112]. A hypothesis is 
that dynamin dephosphorylation stimulates the formation of protein complexes for 
endocytosis but this assumption could not be confirmed in vivo [113]. Amphiphysin 
and endophilin are two potential candidates for phosphorylation dependent 
dynamin-1 binding. These data result from experiments with single domains or in 
vitro experiments but it was not confirmed with endogenous proteins in intact cells 
[100–102]. Furthermore, in a dephosphorylated state, dynamin-1 recruits syndapin-1 
for small vesicle endocytosis [114]. It thus seems that dynamin is able to bind 
different proteins depending on its phosphorylation [113].  
The fact that we were not able to show a binding between dynamin-1 and otoferlin is 
probably caused by the absence of the proline-rich domain. In some studies it was 
reported that proteins interact via a SH3-domain with the proline-rich domain of 
dynamin. Otoferlin does not contain a SH3-domain. Consequently it might be possible 
that an alternative binding motif is present but no information about this is known so 
far. It is possible that the interaction might be mediated by one of the present 
C2-domains. Unfortunately, we could not test whether otoferlin binds to the 
phosphorylated or unphosphorylated state of dynamin because of the missing of the 
two specific phosphorylation sites in the proline-rich domain in our construct. 
Furthermore, it has to be considered that other posttranslational modifications in 
otoferlin might be necessary to establish a binding. In this case also the possibility 
that this interaction is simply an indirect interaction mediated by another protein had 
to be kept in mind. Recent proximity ligation assays done by Alexandra Müller at the 
4 Discussion 
4.3 Identification of possible interaction partners of otoferlin  
96 
lab of Dr. Ellen Reisinger showed that otoferlin exists in close proximity (≤40 nm) of 
dynamin. For further information about a direct or indirect interaction these proteins 
have to be tested in co-immunoprecipitation experiments.  
 
To address more proteins which are known to be involved in endocytosis clathrin, 
endophilin and synaptojanin have to be considered. As described before, clathrin is a 
main component in endocytosis and it forms so called triskelion structures which are 
composed of three clathrin heavy chains and three light chains. These clathrin 
triskelions assemble into a lattice to deform the plasma membrane into coated pits 
which are released through fission by dynamin from the plasma membrane [106]. In 
our studies the clathrin heavy chain was found in three of nine pull-down 
experiments. Because of the known interaction between the β2-subunit of AP2 and 
clathrin, which enables the formation of the clathrin structure, two possibilities of 
interactions have to be considered. On the one hand it might be possible that otoferlin 
directly interacts with clathrin while on the other hand it is likely that it is an indirect 
interaction mediated for example by AP2 or amphiphysin, which are known to 
interact with clathrin [95,106,115].  
The accessory protein endophilin was reported to interact with dynamin and 
synaptojanin which are known to be involved in scission and uncoating events in the 
synapse [103,104]. It is a member of the Bin-Amphiphysin-Rvs (BAR) domain protein 
family. This BAR-domain is able to sense curvature in the membrane and can also 
generate these curvatures [116,117]. BAR-domain containing proteins acting in 
endocytic transport processes and the binding to dynamin occurs through the 
SH3-domain of endophilin to the proline-rich domain of dynamin [114,118,119]. Due 
to the binding to the two mentioned proteins it is assumed that endophilin acts as a 
molecular switch linking the fission process and the uncoating of vesicles during 
recycling but the exact mechanism is still unknown [104].  
Vesicle uncoating after fission is mainly facilitated by an interaction of endophilin 
with synaptojanin [104,105,120]. Synaptojanin is an inositol-5-phosphatase which is 
enriched in nerve terminals, it is as well able to bind to the SH3-domains of 
amphiphysin [121]. Moreover, synaptojanin interacts with amphiphysin, which in this 
process binds to the proline-rich tail of synaptojanin [103,122]. Recent studies 
suggest that synaptojanin might play a direct role in the actual fission reaction [104]. 
Our pull-down studies identified endophilin three times and synaptojanin two times. 
Due to the suggested role of otoferlin to function in a late step of exocytosis and the so 
far known function of endophilin and synaptojanin both are feasible interaction 
partners of otoferlin. Still, an indirect interaction cannot be excluded in this case.  
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All the proteins identified from pull-downs and discussed above are involved in 
different steps of endocytosis. Most of them interact with each other and all are 
potential interaction partners of otoferlin. The interaction between AP2 and otoferlin 
was reported as a direct interaction but in all other cases both a direct and an indirect 
interaction has to be considered. For further information about the ability to bind to 
otoferlin more individual studies should be done.  
Three other proteins were identified in our studies, one of them being the protein 
14-3-3. The 14-3-3 family consists of seven isoforms which show high sequence 
similarity. The results of our pull-down experiments show all seven isoforms of the 
14-3-3 protein. The interaction between proteins involved in the regulation of the cell 
cycle, intracellular trafficking/targeting, signal transduction, cytoskeletal structure 
and transcription is modulated by the 14-3-3 protein. In regulatory processes of 
14-3-3 the involved proteins often show a distinct preference for a specific isoform 
[65]. These interactions are often dependent on phosphorylation sites of the 
interacting protein or the 14-3-3 isoforms themself [123]. Three isoforms of the 
14-3-3 protein (β/α, ζ, θ) have been identified as highly enriched in hair cells [124]. In 
our studies out of nine experiments the θ isoform was found five times, ε and β/α 
four times, η and ζ/δ three times, γ twice and σ only once. It might be possible that 
the 14-3-3 protein interacts with otoferlin or the indirect interaction is mediated by 
another protein. Furthermore it needs to be tested if all existing isoforms are 
potential interaction partners.  
In five out of nine experiments Rab-7A was identified as potential interaction partner. 
Rab proteins form the largest subgroup within the Ras-super-family. They are small 
monomeric GTPases/GTP-binding proteins and have been identified in several 
cellular functions like growth, protein trafficking, transmembrane signal transduction 
as well as targeting and fusion of membrane bound organelles [125,126]. The Rab-7 
isoforms are involved in the control of late endocytic trafficking [127]. Additionally, 
we found the Rab-3A and Rab-3C in two experiments. Both isoforms were suggested 
to function in vesicle docking or exocytosis [9,128]. This could be a good indication 
for a possible interaction with otoferlin.  
The last identified protein was OPA1. OPA1 belongs to the dynamin family and shares 
a number of structural features with the other family members. Like dynamin, OPA 
consists of the GTPase-, the middle and the GTPase effector domain. It lacks the 
C-terminal proline-rich and the pleckstrin homology domain but contains a 
mitochondrial import sequence (MIS), two hydrophobic sequences and a coiled-coil 
domain at the N-terminal part [129]. OPA1 has an important role in mitochondrial 
fission. The OPA1 knock-out is lethal; the mice lose viability around embryonic day 
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nine. Therefore the importance of OPA1 during early development is assumed [130]. 
Furthermore OPA1 plays a role in autosomal dominant optic atrophy which affects 
the retinal ganglion cells and the axons forming the optic nerve and leads to 
progressive visual loss. Recently some OPA1 mutations were identified to occur in the 
GTPase domain of the protein resulting in deafness beside visual loss [131]. In case of 
OPA1 an additional proximity ligation assay was performed by Alexandra Müller 
which confirms that otoferlin and OPA1 exist in close proximity. Again 
co-immunoprecipitation assays in HEK-cells could give information about a direct or 
indirect interaction.  
In summary, we identified a group of potential interaction partners which are 
involved in trafficking processes, endocytosis or exocytosis. In consideration of the 
proposed function of otoferlin all of them would be reasonable candidates. Further 
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4.4 Thermal stability of otoferlin C2-domains 
Thermal shift assays were performed to analyze the thermal stability of otoferlin 
fragments in absence and presence of Ca2+. A low Ca2+-concentration of 200 µM was 
chosen to specifically study effects of Ca2+ on high affinity binding sites. Through 
binding of Ca2+-ions to the C2-domain top loop region a change in the melting 
temperature is expected. The obtained data show that for some domains the thermal 
stability is influenced by Ca2+ whereas for other no effect could be detected. 
Furthermore, it was observed that the combination of different fragments can 
increase the melting temperature as well. The C2ABC-fragment was measured alone 
and in combination with the domains C2B, C2C, C2E and C2F. All combinations were 
tested both in absence and presence of Ca2+. The C2ABC showed no indication of a 
higher thermal stability with or without Ca2+. Similar observations were made in 
combination with the C2C-domain. The melting temperature of a mixture containing 
the C2ABC- and the C2B-fragment increased about 1 °C. A 1 °C higher melting 
temperature was observed before for the single C2B-domain. The addition of Ca2+ to 
both samples did not result in any changes. This suggests that the C2B-domain forms a 
complex with the C2ABC-fragment which is more stable than C2ABC alone. The same 
results were obtained for the combination of a fragment containing only the C2A- and 
C2B-domains of the protein together with the single C2B-domain. In case of C2AB the 
addition of the single C2C-domain resulted as well in an increased melting 
temperature. Additionally, the combination of C2B and C2C showed a higher thermal 
stability in complex whereas the addition of Ca2+ did not significantly change the 
melting temperature of afore mentioned combinations. Based on made structure 
predictions and the absence of aspartate residues in the top loop regions it was 
proposed that neither of these domains are able to bind Ca2+ [20]. Beside these 
results are in good agreement with the obtained results by MST. From this follows the 
question which function these non Ca2+-binding C2-domains have in the overall 
structure of the protein. Several C2-domains are reported not to bind Ca2+, in some 
cases these domains are responsible for folding of the overall structure or 
protein-protein interactions [29,31]. The increased temperature especially through 
addition of C2B suggests that the domains C2B and C2C are able to stabilize the formed 
complex. 
In contrast to the first three C2-domains of otoferlin a different observation was made 
for the domains C2E and C2F. The addition of these two domains to the C2ABC- or 
C2AB-fragment did not result in an increase of the melting temperature. But the 
addition of Ca2+ to the samples causes this effect. In both cases the melting 
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temperature rises at least 1 °C. This result is also in accordance with the data from 
literature and the results from our MST studies. The last three C2-domains were 
proposed to bind Ca2+ [20]. For the C2F-domain of the protein we could confirm the 
made assumption by performing MST measurements.  
Based on these findings it can be hypothesized that the first three C2-domains play an 
important role in structural arrangement and stability of the protein. Furthermore 
they can be involved in protein-protein interactions. The last three C2-domains on the 
contrary are probably responsible for Ca2+-binding which might lead to the activation 
of the protein. Similar findings were reported for example in case of synaptotagmin 
the activation of which is triggered by Ca2+ [132] just as PKC activation results from 
interactions with Ca2+ and phospholipids [133]. In case of Syt 3 it was shown that the 
binding to Ca2+ changes the tertiary structure of the C2-domains [45]. Esyt 2 in 
contrast shows no conformational changes in absence or presence of Ca2+ [43]. The 
different overall arrangement of the two mentioned proteins may result because they 
belong to different topology types. Syt 3 exists in the type I topology whereas Esyt 2 is 
type II [42,44]. Based on the fact that otoferlin C2-domains are predicted to be as well 
in a type II topology it might be possible that a similar behavior like for Esyt 2 occurs. 
The linker region between the C2A and C2B in Syt 3 contains seven amino acids and 
the Esyt 2 linker 14 amino acids [43,44]. In otoferlin the linker regions are much 
longer suggesting that it might be possible that in case of otoferlin no direct 
interaction between the domains takes place. The shortest otoferlin linker is between 
the C2B- and C2C-domain. It consists of 41 amino acids therefore a high flexibility in 
the C2-domain arrangement is likely. All other linkers in otoferlin are at least 120 
amino acids in length [20]. 
As an additional experiment the I515T-mutant was tested for thermal stability in 
comparison to the wild type fragment. The exchange of isoleucine to threonine in the 
C2C-domain of the protein leads to a temperature sensitive mutant. If the body 
temperature of affected people rises 1 °C they become deaf [51]. In experiments 
studying recombinant proteins, the melting temperature for I515T was found to be 
more than 1 °C lower than for the wild type. The addition of Ca2+ in both cases did not 
change the temperature. These findings explained for the first time the phenomenon 
of temperature sensitive deafness on a molecular level. This confirms the assumption 
that the mentioned amino acid exchange is responsible for the behavior of the 
protein. 
To sum it up the thermal shift assay is a nice method to perform protein stability 
tests. The advantages of this method are (i) only a small amount of protein is needed, 
(ii) the TM value is determined with high precision and (iii) a multiplicity of reaction 
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conditions can be tested in parallel [134]. To confirm the obtained data with another 
method circular dichroism spectroscopy measurements can be tried in the future 
[43,135,136]. The results of the performed thermal shift experiments show that the 
C2-domains of otoferlin behave differently. For some of the tested domains an 
increase of the melting temperature was measured by adding either other C2-domains 
or through addition of Ca2+. Using a dilution series of Ca2+-concentrations it might 
even be possible to determine a Kd value for Ca2+-binding of some proteins.  
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4.5 Crystallization of otoferlin 
Almost all purified otoferlin fragments were tested in several crystallization screens 
with different protein concentrations and temperatures. Only for the protein 
fragment containing the domains C2A, C2B and C2C very small crystals were obtained. 
Curiously the gained crystals resulted from a condition that was tested before 
multiple times with the same concentrations and temperature but no crystals grew in 
the previous trials. Through condition optimization the size of the crystals could be 
increased and a data set of the native crystal was collected. Solving the structure by 
molecular replacement using the known structures of otoferlin C2A or other 
C2-domains was not successful. In order to solve the phase problem, protein 
expression containing selenomethionine was tried but unfortunately no protein could 
be expressed. Further trials to obtain an anomalous signal from iodine, bromide or 
mercury failed as well. Either the co-crystallized or soaked ion was not found within 
the crystal or mostly the tested crystal did not exist as a single crystal. Seeding was 
tried for native single crystal formation. Neither the addition of the diluted crystal 
solution by pipetting nor streak-seeding resulted in any crystals. The structure 
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Table 6-1 List of oligonucleotides used for restriction site or StarGate cloning and for creation of point 
mutations.  
Nr Name Sequence 
1 mOtof_C2A_SH_F GAGAGGATCCATGGCCCTGATTGTTCACCTCAAG 
2 mOtof_C2B_SH_R GAGAGAATTCTAGTCGTCCTCATCCGTCTCGTTG 
3 C2B-BamHI_F ATATGGATCCATGGAGGACCTGGACCACC 
4 C2B-EcoRI_R ATATGAATTCTAGTCATCCTCATCTGTCTCGTTG 
5 C2C-BamHI_F TGGATCCACAGATGAGGATGACATTGAAGG 
6 C2C-EcoRI_R TGAATTCTACTCTGAGACAGGTGTGGCCTG 
7 C2E-BamHI_F ATATGAATTCTACTCATCTGTGGGCTTCCTCTG 
8 C2E-EcoRI_R ATATGAATTCTACTCATCTGTGGGCTTCCTCTG 
9 C2F-BamHI_F ATATGGATCCAACCCTGACAAGCCAGGC 
10 C2F-EcoRI_R ATATGAATTCTAGTCAGGTTCATTGCGAGCCAG 
11 pga-fwd1 CAGCAGGAGGGCAAACAGGACACAGACGTAC 
12 pga-fwd2 ATATGGATCCAACCCTGACAAGCCAGGC 
13 pga-rev1 ATATGAATTCTAGTCAGGTTCATTGCGAGCCAG 
14 pga-rev2 GTCCTGTTTGCCCTCCTGCTGGCCCTTCAG 
15 C2ABC SG F AGCGGCTCTTCAATGATGGCCCTGATTGTTCACCT 
16 C2ABC SG R AGCGGCTCTTCTCCCCTCCGAGACAGGCGTGGC 
17 SG-C2ABC-kurz-R AGCGGCTCTTCTCCCGGCCCGGAAGGACACACC 
18 mOtof_C2D_SH_F GAGAGGATCCAAGCTGGAGCTCTACCTGTG 
19 mOtof_C2F_SH_R GAGAGAATTCTAATCAGGTTCATTGCGAGCCAG 
20 R-mDyn1-PRD AGCGGCTCTTCTCCCCGTGCTGACGGTGGTCGT 
21 F-mDyn1-PRD AGCGGCTCTTCAATGATGGGCAACCACGGCATG 
22 I515T-F ATGAAGGTGCAGACCCGGGACTCTGAC 
23 I515T-R GTCAGAGTCCCGGGTCTGCACCTTCAT 
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24 F-43-G541S CCAGCCTGGGTGAACATGTACAGCTCCACG 
25 R-43-G541S TGTGTAGTTGCGCGTGGAGCTGTACATGTT 
26 C2C-Thr->Asp-F CTGCCCCGGATGAACGACAGCCTCATGGCCAAC 
27 C2C-Thr->Asp-R GTTGGCCATGAGGCTGTCGTTCATCCGGGGCAG 
28 D1N-F GGAGAGAAGTCCAGTAATATTTTTGTGAGGG 
29 D1N-R CCCTCACAAAAATATTACTGGACTTCTCTCC 
30 DN-fwd3 CACCCTGCAGATATGGAACGCTAACATCGGCTGACGAC 
31 DN-rev1 ATATGAATTCTAGTCAGGTTCATTGCGAGCCAG 
32 DN-fwd2 CACCCCCTCACAAAAATGTTAGAGCTCTTCTCTCCCGTG 
33 DN-rev3 GTCGTCAGCCGAGAAGTGGTTAGCGTTCCATATCTGCAGG
GTG 
34 DN-fwd1 CACGGGAGAGAAGAGCTCTAACATTTTTGTGAGGGGTG 
35 DN-rev2 ATATGGATCCAACCCTGACAAGCCAGG 
36 D4N-F GCCAATAACTTCCTGGGGGCCATCGAGCTGGACCTG 
37 D4N-R GGCCCCCAGGAAGTTATTGGCTGAGAAGTGGTCAGC 
38 E1804del-F TACCTGGCGGCCGAAAAGATCGTTATGTCC 





6.2 Tested crystallization conditions 
Table 6.2-1 Crystallization trials of the C2ABC-His6-fragment of otoferlin. Eleven different 
crystallization screens were used. The different tested protein concentrations and temperatures are 














































































































BL21 (DE 3) 





















x x x x x x x x x x x 
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x x x x x x x x x x x 
C2ABC-His6 
4 mg/ml (4 °C) 
x x x x x x x x x x x 
C2ABC-His6 
5 mg/ml (4 °C) 
x x x x x x x x x x x 
C2ABC-His6 
5 mg/ml (4 °C) 
Chelex 
x x x x x x x x x x x 
 
 
Table 6.2-2 Crystallization trials of the His6-C2AB-fragment of otoferlin. Eleven different 
crystallization screens were used. The different tested protein concentrations and temperatures are 





































































































x x x x x x x x x x x 
His6-C2AB 
5 mg/ml (4 °C) 






Table 6.2-3 Crystallization trials of the GST-C2E-fragment of otoferlin. Eleven different crystallization 
screens were used. The different tested protein concentrations and temperatures are shown in the left 
































































































x x x x x x x x x x x 
 
 
Table 6.2-4 Crystallization trials of the GST-C2B-fragment of otoferlin. Eleven different crystallization 
screens were used. The different tested protein concentrations and temperatures are shown in the left 











































































































































x x x x x x x x x x x 
GST-C2B 
5 mg/ml (4 °C) 
x x x x x x x x x x x 
GST-C2B 
5 mg/ml (4 °C) 
+Ca2+ 
x x x x x x x x x x x 
 
 
Table 6.2-5 Crystallization trials of the Strep-C2ABC-fragment of otoferlin. Eleven different 
crystallization screens were used. The different tested protein concentrations and temperatures are 

































































































x x x x x x x x x x x 
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Table 6.2-6 Crystallization trials of the GST-C2F-fragment of otoferlin. Eleven different crystallization 
screens were used. The different tested protein concentrations and temperatures are shown in the left 


















































































































x x x x  x x     
GST-C2F 
4 mg/ml (4 °C) 




x x x x x x 
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Table 6.2-7 Crystallization trials of the GST-C2C-fragment of otoferlin. Eleven different crystallization 
screens were used. The different tested protein concentrations and temperatures are shown in the left 
































































































x x x x  x x     
 
 
Table 6.2-8 Crystallization trials of the GST-C2F-phos-fragment of otoferlin. Eleven different 
crystallization screens were used. The different tested protein concentrations and temperatures are 


































































































Table 6.2-9 Crystallization trials of the GST-C2F-D1N-fragment of otoferlin. Eleven different 
crystallization screens were used. The different tested protein concentrations and temperatures are 





























































































x x x x  x x     
GST-C2F-D1N 
4 mg/ml (4 °C) 
x x x x  x x     
 
 
Table 6.2-10 Crystallization trials of the GST-C2F-D2,3N-fragment of otoferlin. Eleven different 
crystallization screens were used. The different tested protein concentrations and temperatures are 





























































































x x x x x x x x x x x 
GST-C2F-D2,3N 
4 mg/ml (4 °C) 





Table 6.2-11 Crystallization trials of the GST-C2F-D1,2,3N-fragment of otoferlin. Eleven different 
crystallization screens were used. The different tested protein concentrations and temperatures are 




























































































4 mg/ml (20 °C) 
x x x x  x x   x  
GST-C2F-D1,2,3
N 
4 mg/ml (4 °C) 
x x x x  x x   x  
GST-C2F-D1,2,3
N 
4 mg/ml (4 °C) 
    x   x x x x 
 
 
Table 6.2-12 Crystallization trials of the GST-C2F-pga-fragment of otoferlin. Eleven different 
crystallization screens were used. The different tested protein concentrations and temperatures are 


































































































Table 6.2-13 Crystallization trials of the GST-C2F-E1804del-fragment of otoferlin. Eleven different 
crystallization screens were used. The different tested protein concentrations and temperatures are 
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